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Abstract
RNA molecules lie at the heart of living organisms where they are associated with most of
the cellular processes. They have recently emerged as one of the most promising elements
for developing programmable genetic regulatory systems. RNA regulators have been shown
to offer great advantages to harness the power of synthetic biology. Versatility of functions,
predictability of design, and light metabolic cost have turned RNA-based devices into compo-
nents of primordial importance for therapeutic, diagnostic and biotechnological applications.
However, advanced tasks require the use of sequential logic circuits that embed many con-
stituents in the same system. Combining RNA-parts into more complex circuits remains
experimentally challenging and difficult to predict. Contrary to protein-based networks,
little work has been performed regarding the integration of RNA components to multi-level
regulated circuits.
In the first part of this thesis, combinations of variety of small transcriptional activa-
tor RNAs (STARs) and toehold switches were built into highly effective AND-gates. To
characterise the components and their dynamic range, an Escherichia coli (E. coli) cell-free
transcription-translation (TX-TL) system dispensed via nanoliter droplets was used. Cell-free
systems, which constitute an open environment, have removed many of the complexities
linked to the traditional use of living cells and have led to exciting opportunities for the
rational design of genetic circuits. A modelling framework based on ordinary differential
equations (ODEs), where parameters were inferred via parallel tempering, was established
to analyse the expression construct in a qualitative and quantitative manner. Based on this
analysis, nine additional AND-gates were built and tested in vitro. The functionality of
the gates was found to be highly dependent on the concentration of the activating RNA for
either the STAR or the toehold switch. All gates were successfully implemented in vivo,
displaying a dynamic range comparable to the level of protein circuits. Subsequent spacer
screening experiment enabled isolation of a gate mutant with dynamic range up to 1087 fold
change, paving the way towards multi-layered devices where tight OFF-stages are required
for efficient computation. Expanding the repertoire of RNA regulatory parts with efficient
inhibitors would complete the set of logic operations necessary for the building of dynamic
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circuits, such as memory devices or oscillators. The TX-TL system was functionalized with
pre-expressed dSpyCas9, a mutated version of Cas9 without endonuclease activity. Four
functional small guide RNAs (sgRNAs) targeting the sfGFP reporter were engineered and
characterized, all resulting in high repression efficiency. A three-inputs logic circuit contain-
ing toehold, STAR and sgRNA was successfully co-expressed, validating the orthogonality
of NOT and AND gates based solely on RNA-based regulation. In order to minimize interac-
tions which could arise from RNA-circuit of increasing complexity, the TX-TL system was
functionalized with a second protein, the Csy4 endoribonuclease, which selectively binds and
cuts a small RNA hairpin. Normalization of gene expression from various untranslated region
contexts and enhanced processing of three-inputs small RNA operon were demonstrated via
the use of Csy4. Finally, characterizing complex RNA-based circuits requires techniques that
resolves dynamics. To overcome the batch-format limitations inherent to TX-TL systems,
a microfluidic nanoliter-scaled reactor was implemented, enabling synthesis rates to stay
constant over time. Dynamic control of RNA circuitry was demonstrated by modulating
the concentration of ligands, reversing the gene state through the conformational change of
riboswitches.
This thesis shows the potential of a rapid prototyping approach for RNA circuit design
in TX-TL systems combined with a predicting model framework. Taken together, the
characterization of a variety of RNA-parts : activators, repressors, or controllers culminating
into logic modules; and augmented cell-extracts; form a complete RNA-toolbox for cell-free
systems. The leveraging of this unique prototyping platform will ultimately enable the
engineering and the study of highly dynamical RNA-circuits in vitro.
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Zusammenfassung
RNA-Moleküle bilden ein Kernstück lebender Organismen, wo sie mit den meisten
zellulären Prozessen in Verbindung gebracht werden. Sie sind in jüngerer Zeit hervorge-
treten als eines der vielversprechendsten Elemente für die Entwicklung programmierbarer
genetischer Regulationssysteme. RNA-Regulatoren bieten große Vorteile dabei, die Kraft
der synthetischen Biologie zu nutzen. Durch die Vielseitigkeit ihrer Funktionen, der Vorher-
sagbarkeit beim Design und ihrer geringen Stoffwechselkosten sind RNA-basierte Elemente
von grundlegender Bedeutung für therapeutische, diagnostische und biotechnologische An-
wendungen. Fortgeschrittene Aufgaben erfordern jedoch die Verwendung von sequentiellen
Logikschaltungen, die viele Bestandteile in dasselbe System einbetten. Das Kombinieren
von RNA-Komponenten zu komplexeren Schaltkreisen bleibt experimentell herausfordernd
und schwierig vorherzusagen. Im Gegensatz zu proteinbasierten Netzwerken wurden nur
wenige Arbeiten zur Integration von RNA-Komponenten in mehrstufig geregelte Schaltkreise
durchgeführt. Im ersten Teil dieser Arbeit wurden Kombinationen verschiedener kleiner
Transkriptionsaktivator-RNAs, small transcriptional activator RNAs (STARs), und Toehold-
Schalter in hochwirksame AND-Gatter eingebaut. Zur Charakterisierung der Komponenten
und ihres Dynamikbereichs wurde ein zellfreies Escherichia coli (E. coli) -Transkriptions-
Translations-System (TX-TL) verwendet, das über Nanolitertröpfchen verteilt wurde. Zell-
freie Systeme, die eine offene Umgebung darstellen, haben viele der Komplexitäten, die mit
der traditionellen Verwendung lebender Zellen verbunden sind, beseitigt und aufregende
Möglichkeiten für die rationale Gestaltung genetischer Schaltkreise eröffnet. Zur qualita-
tiven und quantitativen Analyse des Expressionskonstrukts wurde ein auf gewöhnlichen
Differentialgleichungen, ordinary differential equations (ODEs), basierendes Modellierungs-
framework erstellt, dessen Parameter durch parallel tempering abgeleitet wurden. Basierend
auf dieser Analyse wurden neun zusätzliche AND-Gatter gebaut und in vitro getestet. Es
wurde festgestellt, dass die Funktionalität der Gatter stark von der Konzentration der ak-
tivierenden RNA für den STAR- beziehungsweise den Toehold-Schalter abhängt. Alle Gatter
wurden erfolgreich in vivo implementiert und wiesen einen Dynamikbereich auf, der mit dem
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von Proteinkreisläufen vergleichbar ist. Ein anschließendes Spacer-Screening-Experiment
ermöglichte die Isolierung einer Gatter-Mutante mit einem Dynamikbereich von bis zu
1087-facher Veränderung, womit der Weg geebnet wurde für mehrschichtige Bauelemente,
bei denen enge OFF-Level für eine effiziente Schaltung erforderlich sind. Die Erweiterung
des Repertoires der RNA-Regulatoren um wirksame Inhibitoren würde die für den Aufbau
dynamischer Schaltkreise, wie Speicherbausteine oder Oszillatoren, erforderlichen logischen
Operationen vervollständigen. Das TX-TL-System wurde mit vorexprimiertem dSpyCas9,
einer mutierten Version von Cas9 ohne Endonukleaseaktivität, funktionalisiert. Vier funk-
tionelle Small-Guide-RNAs (sgRNAs), die auf den sfGFP-Reporter abzielen, wurden konstru-
iert und charakterisiert und wiesen eine hohe Repressionseffizienz auf. Eine Logikschaltung
mit drei Eingängen, die Toehold, STAR und sgRNA enthielt, wurde erfolgreich co-exprimiert
und validierte die Orthogonalität von NOT- und AND-Gattern ausschließlich auf der Grund-
lage der RNA-basierten Regulation. Um Wechselwirkungen zu minimieren, die durch einen
immer komplexer werdenden RNA-Schaltkreis entstehen könnten, wurde das TX-TL-System
mit einem zweiten Protein, der Csy4-Endoribonuklease, funktionalisiert, welches selektiv
eine kleine RNA-Haarnadel bindet und schneidet. Die Normierung der Genexpression ver-
schiedener nicht translatierter Regionskontexte und die verbesserte Verarbeitung von kleinen
RNA-Operons mit drei Eingängen wurde mithilfe von Csy4 demonstriert. Zuletzt erfordert
die Charakterisierung komplexer RNA-basierter Schaltkreise Techniken um Dynamiken zu
erfassen. Um die mit TX-TL-Systemen verbundenen Einschränkungen des Batch-Formats
zu überwinden, wurde ein mikrofluidischer Nanoliter-Reaktor implementiert, der es er-
möglicht, die Syntheseraten über die Zeit konstant zu halten. Die dynamische Kontrolle der
RNA-Schaltkreise wurde durch Modulation der Ligandenkonzentration und Umkehrung des
Genzustands durch Konformationsänderung von Riboschaltern demonstriert. Diese Arbeit
zeigt das Potenzial eines Rapid-Prototyping-Ansatzes für das Design von RNA-Schaltkreisen
in TX-TL-Systemen in Kombination mit einem Modellierungsframework. Zusammengefasst
bilden die Charakterisierung einer Vielzahl von RNA-Teilen wie Aktivatoren, Repressoren
oder Controllern, die in Logikmodulen gipfeln, sowie funktionserweiterte Zellextrakte, eine
komplette RNA-Toolbox für zellfreie Systeme. Die Nutzung dieser einzigartigen Prototyping-
Plattform wird es letztendlich ermöglichen, hochdynamische RNA-Schaltkreise in vitro zu
konstruieren und zu untersuchen.
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1.1 Features of the Synthetic Biology Approach
The term ’Synthetic Biology’ designates a field of research whose establishment in the
scientific community has been reported in the early 2000s. It has been designed as the
’21st century’s fastest growing field of research’ and has led to many promises in terms of
technology output as well as basic fundamental research [24]. Synthetic biology is not a
new discipline per se but rather built upon the more traditional fields of genetic engineering
and molecular biology [18]. However, those fields were usually limited to editing one or
a couple of genes. Synthetic biology aims to use genes and proteins as building blocks to
enable the creation of new functional modules, and ultimately brought together to make
very significant changes in living cells [23]. Performing those heavy modifications has been
made possible by the continuous emergence of novel techniques that has shaped the field
of genetic for the last half century [115]. The first milestone happened with the discovery
of restriction enzymes, and their use for cutting DNA at specific sequence patterns, which
led thereafter to the insertion of the insulin human gene into bacterial cells. Since the first
restriction enzyme, HindII, discovered by Hamilton Smith in 1968, many others have follow,
as well as other breakthrough technologies which are emerging since the late 1990’s at an
accelerated pace [93]. Affordable DNA synthesis and sequencing, high-throughput methods,
and novel cloning strategies enabling the tuning of genes at a large scale have all contributed
to the emergence of synthetic biology as described nowadays.
Those methods have all contributed to the emergence of numerous applications, whose
some of them are already commercially available or near-market production. They have
shown to cover a very wide and diverse area of functions. Bio-sensing, stem-cells repro-
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gramming, point-of-care testing, engineered-cell therapies or bio-production of recombinant
enzymes are a small sample list of what the field has to offer [56]. In 2005, Levskaya
et al. [68] implemented a set of memory devices into bacteria for creating living photograph
based on light-responsive toggle switches producing pigment. Paddon and Keasling [89]
successfully implemented all the chemical pre-cursors to the antimalarial drug artemisinin
into yeast to produce the drug at lower cost in a most reliable manner. Multiple other
enzyme engineering projects are now commercially available or near market production,
such as bio-diesel, bioisoprene (for rubber), or resveratrol [131, 137]. In 2015, the first
complete synthesis and assembly of a minimal bacterial genome containing 473 genes has
been successfully implemented, marking a major milestone for synthetic biology and opening
promising possibilities to tackle a multitude of current research problems [52]. This year,
less than 20 years after the first sequencing of the whole E. coli genome, Fredens et al. [36]
demonstrated the full synthesis of the entire E. coli genome, recoding 18,214 codons to create
an organism with a 61-codon genome, enabling the deletion of a previously essential transfer
RNA. Finally, investigation of genetic programming through synthetic circuits engineering
promise new treatments for incurable or complicated disease treatments. The creation of
gene circuits able to trigger their components in a sequential manner, with diverse expression
patterns such as oscillations, or with sophisticated time-dependent transcription profiles,
bring hopes to program cells with therapeutic behaviors [127].
1.1.1 The Limits of the Engineering Approach
The engineering paradigm brings together most of those projects under the synthetic biology
banner. Several authors have highlighted the importance of the engineering approach for
synthetic biology. An example statement is: "Synthetic biology ... applies engineering
formalism to design and construct new biological parts, devices, and systems for novel
functions or life forms that do not exist in nature" [37]. The idea behind such statement is to
bring the full methodology usually reserved to the classical engineering field (mechanical,
information technology, etc...) to the biological branch. It traditionally involves a cycle of
several steps which can be iterated to improve the overall performance of the final product
[25]. Those steps are:
1. An initial design phase using predictive modeling
2. Optimizing designs based on standard components simulations
3. Hierarchical design
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4. Fabrication using reliable and robust equipment
5. Testing of the finished assemblies using standardised protocol and devices
This protocol would present several advantages when transferred to synthetic biology.
In particular, the use of standardized and well-characterised components would enable the
fabrication of module libraries, which would, therefore, be themselves standardised for
further use in unrelated or related projects. Similar to what electronic components are today
to the television or computers, synthetic biology could take advantage of pre-written libraries
of DNA circuits. The first major attempt in this direction has been the establishment of the
Registry of Standard Biological Parts based on well-characterised ’Biobricks’ comprised
of elementary gene circuit such as promoters, fluorescent reporters and terminators [112].
This idea of using standard parts would confer major advantages to the field of biology.
First, it enables the prototyping of simplified designs where each part has its own described
characteristics and response behaviors to a sample of standardised conditions. Second, it
would spare a tremendous amount of time and money as the bio-engineers could select
a standard device or module in a numerous number of different projects, without having
to re-invent and carefully characterise again the basic parts of their product. Third, the
components of the system could easily be swapped in a plug-and-play configuration, so if a
new better-performing part is released, any current working device could be updated without
having to re-engineer the whole assembly [74]. Those advantages are well-established for the
field of traditional engineering where the properties of modules such as electronic transistors
or IT software libraries are well-known.
However, it has been pointed out that actually only a very small fraction of successful
synthetic biology projects, as for instance the ones mentioned above, have demonstrated the
use of the engineering pipeline. Davies [25] wrote in a recent opinion review that nine out of
the ten most prominent synthetic biology projects have not been using standard components or
predictive models. In other terms, their projects, despite being marketable, do not exhibit the
classical features expected in a traditional electrical engineering enterprise, such as modularity
of the components along with their characterisation in defined standardised conditions. Most
of the projects resulted from a ’Design-Test-build’ paradigm, where optimisation were mainly
made by testing multiple iterating versions of the wet-ware constructs without any input
coming from computer models [94]. Consequently, randomisation and selection of the best
circuits is the current production pipeline of many synthetic biology projects.
This major discrepancy between the definition of synthetic biology and how it is usually
performed emerges generally from the system components. Engineering genetic circuits
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are usually derived from natural molecules, based on nucleic acid sequences encoding for
diverse type of regulators or enzymes. Those sequences are still very poorly understood. For
instance, it is now reasonable to predict the yield of a protein product from a given nucleic
acid sequence, by taking into account known parameters such as the promoter or ribosome
binding site (RBS) strengths. However, many unknown parameters such as sequence genomic
context or unknown intragenic motifs could alter those predictions, requiring the need for
these sequences to be experimentally verified [8]. Moreover, expressing synthetic circuits
or producing recombinant proteins typically involves host cells, for which their whole
understanding is still a very rough draft compared to the extent of their complexity [98]. The
living host, which can range from bacteria to human cells, possess a very dense amount of
endogenous molecules, for which their functionality is not always assessed. Even when their
roles and structures are characterised, there is currently no convincing or systemic solution
to predict potential cross-talks between the implemented gene circuit and the host metabolic
network.
In order to circumvent most of the limitations imposed by cell-based processes, bio-
engineers have recently turned to alternative solutions where they could synthesise proteins
and implement genetic networks in an environment decoupled from the host complexity.
1.2 Cell-Free Systems for Synthetic Biology
Before the massive increase of popularity that cell-free transcription-translation systems (TX-
TL) have known during the last decade, early cell-free protein synthesis (CFPS) experiments
were reported back in the late 60s. One of the most iconic early example was its use to
crack the first codon of the genetic code in 1961 by Nirenberg and Matthei [84]. Cell-free
systems offer advantages closer to engineer objectives compared to the drawbacks of cell-
based processes described in the previous section. Cell-free systems offer an open reaction
environment for biotechnology where the easy addition or removal of reactants increases
dramatically its flexibility compared to in vivo systems [45].
1.2.1 PURE Systems vs. Extract-based Lysates
The two main advantages of using TX-TL systems are linked to the decoupling of the
implemented circuit from their host. First, as the complexity of the biological circuit increases,














Fig. 1.1 Overview of lysate-based TX–TL systems. Cell-free crude extracts can be obtained from the
lysates of various organisms (left). TX and TL processes require the supplementation of additional
NTPs and substrates (ATP, 3-PGA, tRNA and amino acids) in order to sustain the reactions for an
extended period of time (right).
the resource competition increases between the growth of the host and the synthesis of the
circuitry components [69]. The resources become scarce, and a trade-off has to be found
by the cell which will ultimately limit the synthetic circuit output [110]. Hence, in TX-TL
systems, the cell viability is not taken into account anymore and all available resources can
be redirected towards the circuit usage.
Second, as discussed earlier, the implementation of genetic networks into living cells may
create unwanted interactions between the endogenous pathways and the circuit components
[80]. Cell-free extracts do not possess any part of the host DNA anymore, reducing therefore
the complexity of the number of possible interactions. This enables in turn the development
of quantitative models describing more accurately the implemented networks.
Engineers can turn towards the use of two main categories of cell-free systems. The first
one, considered as a "top-down" approach, is based on crude extracts from various organisms
ranging from microbial to eukaryotic cell lines (Fig. 1.1). They are usually obtained by
centrifuging the cell-lysate to remove the unwanted parts such as DNA, debris and unlysed
cells while keeping intact the cell’s machinery. The most popular by far is the one based
on E. coli extract which possesses numerous advantages such as low-cost preparation, very
high-batch yields and a wide range of applications from diagnostic platforms to antibodies
production [81]. Other extracts based on multi-cellular organisms, e.g. insect, HeLa, or
Leishmania tarentolae cells [33, 61, 129], have usually the disadvantage of having low batch
6 Introduction
yield with long and difficult extract preparation. They possess, however, specific applications
such as the production of complex proteins with post-translational modifications [78, 88].
The second category, considered as a "bottom-up" approach, is a cell-free system de-
scribed as protein synthesis using purified recombinant protein elements (PURE) [104]. In
the PURE system, each molecular component required for the transcriptional and transla-
tional processes in E. coli is independently purified and subsequently assembled together.
This method offers a better control over the bio-chemical composition of TX-TL system
than their extract-based counter-parts and can therefore be seen as an ideal environment to
quantitatively describe the ensemble of system species. However, the PURE system is signif-
icantly more costly to produce because of the numerous purification steps needed to obtain
the isolated components. Recently, Lavickova and Maerkl [64] developed a ’one-pot’ method
which considerably decreases both time and cost of the PURE production. However, the
difficulty to use the endogenous host metabolism and proteome in PURE systems compared
to lysate-based systems may limit the functionality of synthetic circuits.
CFPS technologies have enabled the bio-production of diverse recombinant proteins,
with scales ranging from an Eppendorf tube to a reactor of 106 L, with yield reaching up to
9.7 g/L of Green Fluorescent Protein (GFP) in wheat germ extract [31]. In this thesis, the
focus is made on the use of TX-TL reactions towards the prototyping and implementation of
novel genetic networks. Hence, optimising the yield of the cell-free reactions will not be the
main focus but plays an important role in enabling the co-transcription and co-translation
of multiple components with concentrations high enough to be detected with fluorescence
plate-reader or microscope assays.
1.2.2 E. coli-based TX-TL Systems
E. coli cell-free system is the platform that is most often used for in vitro synthetic biology
applications [124]. It demonstrated potential for prototyping and testing novel genetic parts,
allowing rapid characterisation of novel regulatory elements for further in vivo implemen-
tations. Several aspects of E. coli cell-free systems make them particularly suitable for
circuit prototyping [85]. A couple of toolboxes of regulatory elements have been recently
published for this extract, for which dozen parts of various transcription factors, promoters, or
fluorescent reporters have been thoroughly characterised [106, 39]. Moreover, the catalogue
of parts is still increasing, with for instance the recent addition of the CRISPR/Cas9 system
or the evaluation of multiple ribo-regulators [72, 101]. A main concern related to the use of
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Fig. 1.2 Scheme of the TCA cycle for ATP regeneration in TX-TL systems. The TCA cycle is initiated
with the addition of 3-PGA. Abbreviations: PDH, PTA, AcK, LDH stand for pyruvate dehydrogenase,
phosphotransacetylase, acetate kinase, and lactic dehydrogenase, respectively. Figure adapted from
[70].
cell-free systems is that the duration of protein synthesis is usually limited by the available
energy supply in the reaction, since transcription and translation are both ATP-dependant
processes. Fortunately, E. coli TX-TL systems have been the main subject of research
regarding the extension of CFPS lifetime [70]. Enhanced energy regeneration systems have
been developed along the years. The first-generation used expensive phosphoenol pyruvate
(PEP) or pyruvate as an energy source in order to regenerate adenosine triphosphate (ATP)
from the phosphorylation of adenosine diphosphate (ADP) [57]. The lifetime of protein
synthesis was then extended from 2 hours up to 10 hours with current regeneration systems
based on the use of glycolytic intermediate and additions of cofactors such as coenzyme A
(coA) and nicotinamide adenine dinucleotide (NAD) to regenerate ATP from the pyruvate
by-product. In this work, the energy regeneration system is based on 3-Phosphoglycerate
(3-PGA) supplementation, as described from [73] (see Fig. 1.2).
Those elements taken together have contributed to the emergence of E. coli cell-free
system as a leading expression platform with quick and robust preparation protocol and the
most complete system for investigating CFPS.
8 Introduction
1.3 Microfluidics for the Study of Gene-expression
The expression of cell-free reactions can take place in multiple environments. The traditional
approach consists of using a batch-tube format. Even though it is the most simple and
accessible method to express cell-free reactions, it remains limited by several aspects. The
limitations associated to the batch-format are detailed in the 4th chapter. Microfluidics gained
popularity during the last decade among the biotechnology laboratories by bringing further
benefits, such as low-cost fabrication and reduction of the sample volume. Microfluidic
technologies allow the fabrication of cell-like compartments, in order to mimic and execute
cellular functions in a cell-free environment, such as homeostasis (Fig. 1.3). TX-TL systems
can be encapsulated in defined size compartments which can be programmed to perform
certain tasks, such as mixing or merging, offering great opportunities for approaching the
reactions with a control-theory perspective [28]. Indeed, parameter’s environments can
be tuned during the experiment, enabling online monitoring of the reactions and direct
feedback over various optimisation critera, such as resource burden or network modularity.
Niederholtmeyer et al. [82] were the first to propose a functional implementation of a
microfluidic nano-reactor which could sustain TX-TL processes over long period of time
(Fig. 1.3 A). The reactor was successfully used to implement oscillators of increasing
complexity as well as to regulate the ON/OFF gene state through the modulation of an
inhibitor concentration. Mechanically induced trapping of molecular interactions (MITOMI)
devices are a great example of what high-throughput compartment-based microfluidics are
able to achieve. Up to hundreds of parallel chambers can be used on the same device
(k-MITOMI) to simultaneously perform the kinetic analysis of protein-ligand interactions
(Fig. 1.3 B). It has been used for the determination of binding affinities of transcription
factors (TFs), of protein interactions or even of small pharmacological molecules inhibitors
[40]. This is a great improvement for high-throughput, low-cost diagnostics, compared
to the techniques commonly used to determine binding affinities such as forced-based or
optical methods. Additionally, having a good estimate over TFs parameters has been pointed
out as a central element in establishing robust model for synthetic circuitry. PDMS-based
micro-compartments can also be designed for a wide range of sizes and shapes. Karig et al.
[55] have shown that femtoliter-scaled compartment can be made to encapsulate TX-TL
systems, mimicking reaction volumes corresponding to volumes ranging from a single E.
coli to a yeast cell (Fig. 1.3 C). Those volumes enable the observation of stochastic effects
linked to the limited number of molecules confined in the small volume compartments. The
resulting fluorescent traces can be used to infer intrinsic-noise properties of the TX-TL
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system, otherwise more complicated to model in living systems because of the multiple
endogenous noise sources.
Micro-compartments can also be arranged in spacial conformations in order to explore
spatiotemporal patterns encoded by the TX-TL systems. Tayar et al. [122] created DNA-
patterned micro-compartments arranged in a 2D array, enabling front propagation of a
circuit-encoded signal through multiple cascaded chambers (Fig. 1.3 D). This design allowed
the study of reaction-diffusion patterns, enabling the creation of artificial minimal systems in
which one can recreate physical phenomena found in living cells such as self-organisation or
long-range communication. Finally, microfluidics possess an alternative to the fabrication of
micro-compartments with the generation of water-in-oil (w/o) droplets to encapsulate TX-TL
systems. One main advantage over PDMS-based chambers is their ability to be generated in a
high-throughput manner with a dynamical content. For instance, Hori et al. [47] successfully
screened for the optimal concentration parameters of DNA components of an incoherent
forward loop motif. They used three modulated inputs to generate a landscape mapping of
the circuit yield in a single experiment (Fig. 1.3 E). High-throughput droplet platforms have
the potential to close the gap between the use of in vitro and in vivo systems for screening
purpose. Indeed, commercial devices such as Fluorescence-activated cell sorting (FACS) are
already available to sort single cells in encapsulated droplets.
1.4 The Roles and Functions of RNA Molecules
Among the components of synthetic biology toolbox presented over the last sections, RNA
molecules have emerged as one of their most promising elements. They are able to modulate
almost all cellular processes, including transcription, translation, and mRNA degradation
or splicing [11, 15] (Fig. 1.4). They have been shown to occupy essential functions in
physiological and pathological conditions. Number of pathology or genetic disorders are
treated based on RNA-targeted molecules, leading to an increasing wave of new therapeutic
devices, drugs and tools. This in turn has led to the engineering of new regulatory RNAs,
either derived from natural molecules or based on novel mechanisms, with a great diver-
sity of functions and targets. For instance, microRNAs (miRNAs) possess functionalised
secondary structures which upon special conformation, can mediate protein-binding and
promote diverse downstream activities, such as degradation or maturation [38] (Fig. 1.4 E).





















































































Fig. 1.3 Microfluidic platforms for studying TX-TL systems at the nano-liter scale. A) Nanoreactor
enables continuous expression of TX-TL reactions at steady-state for the expression of dynamical
circuits such as a three-nodes oscillator. B) MITOMI device allows the screening and measurements of
binding parameters between DNA and transcription factors. Examples of association and dissociation
curves are shown. C) Femtoliter arrays enclosing TX-TL systems generate stochastic time-course
traces in a high-throughput manner. D) DNA brushes patterned in small compartments allow the
study of diffusion patterns and front-propogation of gene expression. E) Microdroplets generated in a
high-throughput manner allow the screening of component parameters of TX-TL systems, such as the
concentrations of DNA parts.
1.4 The Roles and Functions of RNA Molecules 11
quaternary assemblies, such as ribosomes and spliceosomes (Fig. 1.4 D). These regulators
have been successfully used to address current problems in biotechnology, such as challenges
in metabolic engineering [116] or therapeutic advances [59, 132]
1.4.1 Advantages of RNA-based Devices
Regulatory RNAs possess many features making them particularly suitable for genetic circuit
design with advantages over the traditional use of TFs. One advantage is that RNA molecules
are able to propagate information solely at the transcriptional level, without the need for
intermediate proteins, which reduces the metabolic burden of a cell [54] and increases signal
propagation speed [121]. In other terms, RNA-circuits of the same complexity as the ones
based on TFs could perform equal computational tasks while sparing precious metabolic
resources. Some of the RNA devices can be designed according to simple base-pairing
rules either between RNA:RNA or DNA:RNA interactions. This considerably facilitates
the adoption of a de novo engineering approach, compared to functional in silico protein
design, which is a very challenging task. A growing number of algorithms, mainly based
on free-energy minimisation, have shown the ability to compute secondary structures of
RNA strands and link them to their regulatory functions. With a better understanding of this
relationship between structures and functions, it also became recently possible to generate
RNA sequences according to structural constraints [62, 38]. For instance, Zadeh et al. [136]
have shown the successful use of the computational package Nupack to design and integrate
a multi-co-localised 6-input OR device with toehold switches. However, inferring tertiary
structures of RNA molecules still remains a challenge. Finally, similar to protein-based
systems, RNA-devices are now able to regulate gene expression with very high dynamic
ranges and great specificity for their targets. Conversely, some of the recent engineered RNA
regulators are available in libraries of orthogonal parts or design rules for creating new ones
[44, 16].
1.4.2 A Variety of RNA Regulators
Different RNA regulatory devices like riboswitches [100], ribozymes [102], small transcrip-
tional activators (STARs) [13], toehold switches [44] as well as CRISPR/Cas based systems
are available for building synthetic logic circuits. Lee et al. have recently assembled logic
gates in E. coli based on the combination of engineered CRISPR/antisense RNA (asRNA) and
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Fig. 1.4 RNA molecules display a variety of functions. Figure adapted from [38]. A) Riboswitches
modulate the gene expression by conformation change of their tertiary structure upon ligand-binding.
B) Alternative splicing protein factors bind and process RNA single strand motifs. C) Ribozymes are
capable of catalysing self-cleaving reactions. D) Ribosomal RNA can promote the ordered assembly
of the ribosome complex. E) MicroRNAs can bind to specific proteins and influence downstream
activities. F) Long non-coding RNAs possess many cellular functions such as promoting protein
interactions or epigenetic regulation.
STARs/asRNA [66, 65]. Shen et al. [102] have built layered AND-gates out of engineered
sensor RNA, offering modularity at the post-transcriptional level.
Transcriptional Regulators
Transcription termination events are mainly due to rho-independant transcriptional termi-
nators in E. coli. Briefly, a stable RNA hairpin loop motif of various lengths is followed
downstream by a U-tract sequence comprised of 6 to 9 nucleotides. The U-stretch causes
the polymerase to pause during transcription elongation and the RNA hairpin destabilises
the DNA-polymerase complex resulting in its dislocation. Aside from the newly synthetic
terminators engineered for E. coli based on those critera [17], a set of engineered devices
have used the termination events as a mechanism of gene regulation. Activating or inhibiting
transcription can be achieved by designing antisense small RNAs (sRNAs) that can respec-
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tively stabilise or destabilise weak/strong terminator hairpin [96, 13]. Detailed mechanism
of transcriptional activation by the STARs is given in chapter 2.
Translational Riboregulators
sRNAs can also be engineered to effectively regulate the access of the cell’s ribosomal
machinery to the mRNA. Regulatory sequences inserted in the 5’ UTR of the targeted gene
can occlude the RBS region and switch the genetic device in an OFF state. Upon binding
with the cognate sRNA, structural change occurs and the RBS region is made accessible by
the ribosomes. Various design rules are available for either riboregulators or toehold switches,
for which the RBS sequence is maintained in an unpaired loop and therefore unconstrained
from any sequence design [44, 53]. Repression by sRNAs can also be engineered in a similar
way by simply designing a cognate binding sequence to the RBS and start codon regions,
thus inhibiting translation initiation and elongation processes [9].
Riboswitches
Riboswitches can either act as transcription or translational regulators. They are found
usually in the untranslated region of the regulated gene. They are made of two main domains:
a binding-ligand aptamer, and an expression platform whose conformation changes upon
ligand induction (Fig. 1.4 A). This expression platform triggers or represses gene expression
through a variety of mechanisms. They can inhibit the access to critical parts of the mRNA,
such as the RBS or eukaryotic 5’ cap, promoting or disrupting the formation of intrinsic
terminators in the 5’ UTR region. Different riboswitches sequences have been discovered or
engineered which can sense identical ligands, but act upon different regulation process, e.g.
the theophylline riboswitch which can be found either as a translational or transcriptional
regulator [130]. Most of the existing riboswitches were found in natural organisms, binding to
a wide range of small molecules, vitamins and secondary metabolites. Engineering synthetic
riboswitches de novo from computational methods is still a challenge, but in vitro selection
methods such as systematic evolution of ligands by exponential enrichment have led to the
identification of considerable numbers of novel ligand-binding aptamers [51].
CRISPR–Cas systems
The CRISPR systems are part of antiviral immune systems for counteracting foreign DNA
or RNA that are present in a large percentage of bacteria and archaea species. Multiple
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CRISPR–Cas systems have been found and categorised based on the configuration of the Cas
protein. Of particular interest to gene editing, Cas9 or Cas12a effects a double strand break
of a specific DNA [133]. Their specificity is defined by CRISPR RNA (crRNA) which forms
a complex with trans-activating CRISPR RNA (tracrRNA) for guiding the Cas endonucleases
to their cleavage target. Beyond gene editing, the inactive CRISPR–Cas systems have been
reprogrammed for repressing gene expression at specific location. By fusing them to other
domains such as TFs, they have also been used to activate gene expression. Cas-based
technology has shown to be highly orthogonal due to the design of the single guide RNA
(sgRNA), specific of the gene target (sgRNA is a engineered version of the crRNA and the
tracrRNA expressed together). Extended functionalities have been shown, by extending the
crRNA sequence to recruit other effector proteins or by fusing directly the Cas protein with
the effector of interest.
1.4.3 RNA-based Circuitry
The amount of available RNA parts is therefore in continuous increase, with a catalogue
of hundreds of RNA-based components harboring diverse dynamic ranges, mechanisms of
regulation, complexities of the folded structure, or even different degrees of cross-species
portability [13]. RNA-based circuits built exclusively on those components have led to the
implementation of logic gates, feedback control units, regulatory cascades, or feedforward
control strategies [42]. Successful examples are available for most of those components:
ribosomal circuits based on orthogonal ribosomes with tuned specifities, sRNA-based circuits
mediating complex logic computations, riboswitches combination used as band-pass filters,
or layered complex circuits regulated with multiple small guide RNAs (sgRNAs) and dCas9
[62]. Many of these RNA-based circuitry have found applications in the biotechnological
and medical fields. For instance, the use of RNA-scaffolds have shown to increase hydrogen
output up to 48-times and post-transcriptional classifier has been implemented to selectively
kill cancer cells expressing various levels of different miRNAs [60].
1.5 Aim of this Study
Novel RNA devices with various functions and high dynamic range have been characterised
over the last few years. They have been shown to regulate specific processes of the cell
machinery, e.g. transcription or translation. The previously given examples show the great
potential of RNA-based devices, but also highlight some of the challenges in the assembly
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of highly complex synthetic circuits required for more advanced projects in synthetic biol-
ogy, such as establishing efficient strategies for gene and cell-engineered therapy. Despite
numerous current research projects demonstrating a tremendous potential in RNA-based
circuits, an important limitation remains in the lack of extensive control over the circuit
expression parameters. Indeed, the control of the expression strength and dynamical tim-
ing of RNA-circuitry ,independently from the cellular context, remains a challenging task
[60]. For example, over-expression of the targeted output may be harmful with unwanted
side-effects such as toxicity under excessive activation of engineered cells. Another problem
is that advanced applications reviewed in section 1.1 require a variety of well characterised
and orthogonal devices. One way to address these challenges is to use RNA-based circuits
able to regulate gene expression at different levels. Recent studies have shown the efficient
integration of multiple RNA-activators in the same circuit. For instance, toehold switches
have been engineered into a layered 4-input AND-gate mediated by TFs [44], or integrated
into a co-localised 6-input OR device [43]. Similarly, STARs have been used in tandem
to build logic AND-gates [15]. However, little work has been done yet with respect to the
integration of heterogeneous RNA regulators STARs and toehold switches in the same circuit.
In the 2nd chapter of this work, I present the implementation of advanced logical circuits
based on both translational and transcriptional activators in a cell-free environment. As
explained in section 1.2, cell-free platforms offer an ideal environment to overcome the
current limitations of genetic network implementation in living cells, since every component
of the circuit can be calibrated to the desired level of activation.
Multiplexed RNA-based circuits suffer from another limitation: a low dynamic range,
which is however a critical feature when tight regulation is needed. Indeed, as the complexity
of the circuits increases and involves several regulating RNA species, cross-talk effects can
occur within the circuit. This can either be due to co-folding issues related to high sequence
similarity between RNA components, or impaired functionality due to perturbation of their
tertiary structures in response to various cellular conditions. In the 3rd chapter, TX-TL
systems functionalised with two different proteins are analysed and enable the leverage of
the logic gates from the 2nd chapter with improved functionality and efficiency. The first
one consists of the catalytically "dead" endonuclease Cas9, which can still recognise and
bind to DNA, and therefore be used as an inhibitor of gene expression by blocking the
transcription. This aims to implement novel Boolean operations at the transcriptional level,
and complete the toolbox based on RNA-parts for TX-TL systems. The second protein is
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Fig. 1.5 General outline of the research subjects presented in this thesis. It can be divided into three
main parts represented by, the cell-free extract production, the RNA-based circuitry prototyping, and
the microfluidic metrology.
hairpin. Csy4 processing could serve multiple goals for synthetic biology engineering. It
could normalise the expression level of heterogeneous DNA constructs, as well as insulating
RNA components composed of multiple parts. So far, the co-expression of Csy4 in TX-TL
systems has not been studied and I anticipate it may constitute a useful tool in the context of
RNA-based prototyping. Finally, the 4th chapter is devoted to the implementation of some
of the RNA-toolbox elements through two different microfluidic platforms. I will explore
how the use of compartments with sizes ranging from the femtoliter to the nanoliter scales
could be used for the study of RNA-based circuits in TX-TL systems. I will especially focus
on the implementation of the nanoreactor which provides a technological solution to mimic
cellular homeostasis in cell-free conditions. Taken together, this thesis aims to generate
all the requisites parts necessary for the construction of advanced dynamic RNA-based
networks, such as oscillators or memory devices. Their current implementations based solely
on transcription regulation remain so far at the embryological stage.
Chapter 2
Engineering AND-logic Gates Based on
Heterogeneous RNA Regulators
Fig. 2.1 Cover art made for the publication in ACS Synthetic Biology, "Cell-Free Prototyping of
AND-Logic Gates Based on Heterogeneous RNA Activators". [67]
In this chapter, I am presenting the prototyping and implementation of multiple Boolean
logic circuits in a cell-free system environment. Many synthetic biological circuits have been
based on Boolean regulation, but this work represents the first attempt - to the best of my
knowledge - to combine de novo engineered RNA-regulators to control both transcription and
translation in a highly effective manner. This work has led to a publication in ACS Synthetic
Biology [67] and several research projects have been started on the basis of this work.
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2.1 RNA-based Regulators
Synthetic gene constructs regulated by either STARs or toehold switches have shown unprece-
dented regulatory performance in diverse contexts of transcriptional and post-transcriptional
circuit regulation. Similar to the efficiency of protein-based systems, STARs and toehold
switches regulate gene expression with very high dynamic ranges and great specificity for
their targets. They are either available as libraries of orthogonal parts or with design rules for
creating switches de novo [44, 16]. Additional reasons have led me to chose the STARs and
toehold switches. Firstly, they are able to control transcription and translation independently,
delivering a promising option for applying multiplexed regulation to virtually any gene (in E.
coli at least). Secondly, using such a multi-level regulator system has been shown to increase
the dynamic range of gene expression [128] by reducing dramatically the OFF-level of a gene
otherwise leaky either on the transcriptional or translational level. Thirdly, both systems have
been thoroughly characterised with fine-tuned sequences or coupled with various synthetic
parts, turning them into candidates of choice for integrated circuits [77, 125]. Finally, because
both switching mechanisms are based on Watson-Crick base pairing, gate design could be
aided by the growing number of algorithms for computing secondary structures or solve
inverse structure problems from the sequences of nucleotides given as an input [35, 41].
2.1.1 Characterisation of Single Activators in TX-TL
Mechanisms and implementations
In order to build multilevel RNA-regulated AND-gates based on the STARs and toehold
switches, the first step was to test their functionality as independent activator unit in TX-TL.
STARs are small RNAs designed to form RNA-terminator hairpins. Synthetic STAR antisense
sequences can be co-expressed to disrupt the formation of these intrinsic terminators placed
upstream of the 5’ UTR of the regulated gene - called in this thesis - targets. In the absence
of the anti-terminator STAR activator, the STAR-target leads to an early rho-independent
termination of the regulated transcript (see Fig. 2.2 A. The toehold system controls gene
expression at the translational level and also contains a small antisense RNA which is called
trigger. In the absence of the trigger, the toehold blocks the RBS. The trigger invasion in
the toehold region leads to a conformation where the RBS can be accessed by the ribosome
and translation can thereby occurs (see Fig. 2.3 A). Thus both devices become active in the
presence of an interacting antisense RNA, either trigger or STAR activator.
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Fig. 2.2 Small Transcriptional Activator RNAs regulate gene expression at the transcriptional level.
A) Schematic of the STARs mechanism. B) ODEs model for the single STAR activator with species
labels corresponding to the one written on the schematic.
For the experimental implementation, I used a two-plasmid-system similar as the one
used by Chappell et al. [13]. One plasmid contained the small activating RNA, which is
driven by the strong constitutive J23119 promoter (Anderson collection). The other plasmid
codes for the super folder GFP (sfGFP) [92] reporter gene, which is also driven by the J23119
promoter. Either the STAR target or the toehold switch sequence is placed upstream of the
reporter gene start codon to control its expression. In both plasmids, the t500 terminator
is used to terminate transcription. For the in vivo experiments, the activator cassettes were
combined in the same plasmid. The parts and plasmid constructs are available in the material
chapter, in section 6.19 and 6.20.
Characterisation in TX-TL
The expression of the most efficient STAR from the original publication (STAR AD1) [13]
together with one of the top-performing engineered toehold switches (toehold 2) [44] were
initially characterised. Dose response curves were generated for each part using an E. coli
cell-free TX-TL system by varying the concentration of the activator plasmid. I used a final
reaction volume of 2 µl by dispensing cell extract, energy buffer and plasmid DNA with the
help of a liquid handling robot (I-Dot). The reporter plasmid concentration was 2 nM, and
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Fig. 2.3 Toehold switches regulate gene expression at the translational level. A) Schematic of the
toehold switch mechanism, with and without trigger activator. B) ODEs model for the single toehold
activator with species labels corresponding to the one written on the schematic.
I varied the concentration of activator plasmid (trigger 2 or STAR AD1) between 0-22 nM.
Each DNA sample was independently calibrated beforehand in the I-Dot to insure that the
dispensed volume properly fits to the dose-response curve. The results of the endpoint
measurements are presented in Fig. 2.5 B and individual trace kinetics are presented in
Fig. 2.4.
The TX-regulation-system and the TL-regulation-system reached saturation at about 20 nM
of STAR plasmid and 7 nM of trigger plasmid, respectively. Similar to previous in vivo
data [44, 13], the toehold 2 has a three times higher dynamic range than the STAR AD1.
Rather than due to impaired functionality, those lower dynamic ranges could be attributed
to the TX-TL system. Previous results have highlighted the decrease in dynamic ranges
for RNA devices when transitioning from in vivo to in vitro [72]. This is likely due to the
batch-reaction format, where the synthesised protein accumulates in the OFF-state without
getting diluted as in a dividing cell. The dose-response relationships follow either a linear
response for STAR AD1 or a fast saturation curve for toehold 2 activation. This difference
may be explained by the longer time (mRNA life-time) in which the trigger RNA can bind
and invade the stem of the toehold switch compared to the transient event characterising
the STAR termination [77]. To optimise the sfGFP read-out (Suppl. Fig. 2.6), I tried to
increase the reporter plasmid concentration to 6 nM. This led to a significant increase in
translated sfGFP and therefore strength of the fluorescent signal. However, the concentration
of activator plasmid needed to reach the plateau tripled from 7 nM to 20 nM, suggesting that
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Fig. 2.4 Kinetic characterisation of toehold 2 and target AD1 in presence of 2 nM of reporter template,
either toehold2-sfGFP or targetAD1-sfGFP. Yellow lines correspond to the averaged experimen-
tally measured fluorescence. Black shaded regions represent the experimentally measured standard
deviation. Concentrations written in gray in the background correspond to the activator plasmid
concentration, either trigger 2 or STAR AD1 activator plasmid.
RNA polymerases were not saturated yet with 2 nM of DNA template. Because such high
DNA concentrations caused issues with dispensing and to calibrate the samples in the I-dot
adequately, I kept the reporter plasmid concentration set at 2 nM in the following experiments.
The dynamic range of around 20-fold was unaffected by the different concentration levels of
the reporter plasmid.
2.1.2 Mathematical Modeling of Single Components
Cell-free system reactions in bulk-sized format have the advantage to offer a deterministic
framework based on the chemical species present in the system. Many examples have shown
that traditional ODE models have led to convincing results to describe and predict synthetic
circuits in a cell-free environment [79, 49]. Based on the TX-TL dose-response kinetics for
the STAR AD1 target and the toehold 2 shown in section 2.1.1, coarse-grained parameterised
ODE-models were built for both individual activating systems.























































































































Fig. 2.5 Dose response curves of TX-TL reactions with 2 nM of regulated reporter plasmid and titrated
trigger 2 or STAR AD1 activator. A) Endpoint fluorescence measurements and B) sfGFP production
rates are presented. Rates were determined by computing the slope in the linear regime of each
time-course trace. Errors bars represent the standard deviation over three independent experiments.
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Fig. 2.6 Kinetic characterisation of toehold 2 switch in presence of 6 nM of toehold2-sfGFP template.
Yellow lines correspond to the averaged experimentally measured fluorescence. Black shaded regions
represent the experimentally measured standard deviation. Concentrations written in gray correspond
to the activator plasmid concentration, i.e trigger 2 encoding plasmid.
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Table 2.1 Description of species and kinetic parameters used for the modeling of TX and TL-regulated
components.
Model species Definition
RS,RT RNA activators for STAR and trigger
R sfGFP reporter mRNA
Ds,DT DNA template for STAR and trigger activators
DG sfGFP reporter DNA template




ks,kT Transcription rate of the STAR and trigger activators
kR Transcription rate of the sfGFP reporter
kT L Translation rate of the sfGFP reporter
ds,dT Degradation rate of the STAR and trigger activators
dR Degradation rate of the sfGFP reporter
α Maturation rate of the sfGFP reporter
NS Hill coefficient of the target-STAR binding
NT Hill coefficient of the toehold-trigger binding
KS Dissociation constant of the target-STAR binding
KT Dissociation constant of the toehold-trigger binding
pS, pT Activation probability of the STAR and trigger
The ultimate goal was to infer and use the parameters from those individual activator
models to predict the performance of the assembled AND-gate.
For each model, a minimal number of parameters and species were used to account for the
unidentifiability of the parameters because the sfGFP was the only species being measured.
The models were mainly based on mass-action kinetics except for the TX- and TL-regulation
by the STAR and trigger activators, for which Hill-kinetics was employed to capture the
corresponding dose-response shapes. The detailed systems of ODEs can be found in the Fig.
2.2 B for the STAR activator and in Fig. 2.3 B for the toehold switch. Table 2.1 describes the
list of species and parameters used for those models.
Once the basic set of equations for ODEs were set up, the multiple parameters have to be
fitted to the experimental results. Taking rates directly from the literature and applying them
in our system was not suitable as a huge variance exists between cell-extracts, constructs
assembly, and even laboratories with similar conditions performing CFPS [22]. Additionally,
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Fig. 2.7 Calibration of single activator component. A) posterior predictive distribution of the toehold-
trigger 2 system for 2 nM input plasmid concentration. Input concentrations of trigger activator
plasmid are written in grey; black: experimental data; red: median of parameterised model according
to identified parameter posterior distribution displayed in (B); green: observation model corresponding
to experimentally measured standard deviation and assumption of normally distributed observation
errors, 95%-quantil and 5%-quantil. B) parameter posterior distributions of the toehold-trigger 2
system based on 150 000 samples in the logarithmic space. Univariate distributions are on the diagonal,
bivariate distributions on the off-diagonal. The blue to yellow scale indicate the low to high density
values. Details of the implementation can be found in section 6.1.5.
some of them were not available (like for the dissociation constant of the activators). The
kinetic model curves of the mature sfGFP of the two single parts had therefore to be calibrated
to the experimental data. A mathematician researcher from the BCS group, Maleen Hanst,
collaborated on this project for implementing a Bayesian inference method with Markov
chain Monte Carlo sampling [50]. To improve the convergence speed compared to standard
approaches, she performed parallel tempering, a modification of the Metropolis-Hastings
algorithm (for details see section 6.1.5). STAR AD1 and toehold 2 were calibrated to the
experimental dose-response corresponding to different input concentrations of activator
plasmid. The resulting parameter posterior distributions and the corresponding model
kinetics for toehold2-trigger2 systems are shown in Fig. 2.7. An appropriate set of parameters
posteriors were therefore found for all concentrations to closely capture the dose-response
kinetics. This is not only useful to determine the best fitting set of posterior parameters, but
also gives some clues about the general system behavior. For instance, for the toehold 2
system, a positive correlation is observed between the transcription, kT, and degradation,
dT, rate of the trigger RNA, while the transcription, kR, and translation, kTL, rate of the
reporter are negatively correlated. This matches expectations, since the higher the TX-rate of




























= kS · DS   dS · RS
dRT
dt


















· R   ↵ · G
dGm
dt





















































































































































































= kS · DS   dS · RS
dRT
dt


















· R   ↵ · G
dGm
dt




= S · S   dS · RS
dRT
dt



















· R   ↵ · G
dGm
dt




= kS · DS   dS · RS
dRT
dt


















· R   ↵ · G
dGm
dt





= kS · DS   d · R
dRT
dt

















· R   ↵ · G
dGm
dt




= kS · DS   dS · RS
dRT
dt


















· R   ↵ · G
dGm
dt
= ↵ · G
1
Fig. 2.8 Schema of the computational RNA-based AND logic gates based on transcriptional (TX) and
translational (TL) control. A) TX is regulated through the presence or absence of a STAR activator.
TL is regulated through the binding of the trigger RNA to the linear toehold region. Both types
of small RNA are required to activate the gene expression. B) Parameterised ODE-model of the
AND-gate as a combination of the single part models. Details regarding the parameters, species, and
single part models can be found in the table 2.1 and section 6.1.5.
the reporter mRNA is, the lower its TL-rate should be to reach the measured fluorescence.
Finally, the model was able to capture the steep increase between 1 nM and 4.1 nM input
concentration of activator plasmid (see Fig. 2.8). This is possible due to the Hill-kinetics
equation used to model the regulation.
2.1.3 A Prototype Gate for Multi-level Regulation
Mathematical Modeling
After demonstrating the proper function of the single activators STAR AD1 and toehold 2
in TX-TL system and building an ODE framework containing fitting parameters for a wide
range of concentrations, I wanted to assess the ability of the independent models to be joined
in order to predict the behavior of Boolean RNA-based circuits. Therefore, an ODE model
of the AND-Gate controlling the sfGFP production based on both STAR and toehold was
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Fig. 2.9 Computational dose-response of AND-gate based on STAR AD1 and toehold 2 components
after 180 minutes of expression. Experimental data are represented by the black dots, and the variance
represents the standard deviation over three replicates.
built from single part models and their inferred parameters (maximum a posteriori values).
In this new AND-gate model, the transcription process was regulated by the STAR and the
translation by the toehold switch. The parameters associated with the sfGFP mRNA such
as maturation time α and kR were therefore averaged over the inferred parameters from the
single component models.
The model prediction of the gate can be seen in Fig. 2.9. The plateau or maximal
activation threshold was reached with approximately three-fold more STAR activators than
trigger. In particular, the model predicted a high leakage for 0 nM STAR AD1 plasmid input
concentration.
Experimental Validation
The next step was to implement the AD1 target-toehold 2 gate in TX-TL to verify the
prediction of the in silico model. The STAR AD1 target and the toehold 2 switch were
placed in tandem upstream of the sfGFP reporter gene without further re-engineering (see
Table 6.17). Guided by the model, a combination of 42 concentrations was tested (six
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Fig. 2.10 In vivo characterisation of the prototype gate based on STAR AD1 and toehold 2. Fluores-
cence endpoint measurements of the gate in top10 E. coli cells in presence (+) or absence (-) of the
trigger/STAR DNA-encoded activators.
concentrations for the trigger 2 and seven for the STAR AD1). The predictions of the AND-
gate model captured the qualitative trend of the experimental characterisation (Fig. 2.9). The
TX-TL endpoints at 180 minutes fit to the predicted values of the sfGFP leakage along the
STAR concentration gradient when no trigger is present. Some qualitative disagreements are
observed at intermediate concentrations of activators, i.e. on the surface slope.
Predicting transcriptional leakage in vitro could also provide insights into the in vivo
behaviour. Therefore, E. coli cells were transformed with the same reporter plasmid as
used for the TX-TL measurements. This plasmid contains the p15A origin of replication,
which leads to a low plasmid concentration inside the cell. For the activators, a plasmid
with the ColE1 origin of replication was used, which leads to a high copy number inside
the cell. I thought this configuration would mimic the conditions studied in TX-TL, since
it reflects the lower amount of DNA reporter used there. It would be interesting in future
works to swap the constitutive promoters with an inducible system[106], and reproduce
in vivo, the dose-response shape of each activator in vivo. To analyse the behaviour of
the AND-gate, the E. coli cells were co-transformed with an activator plasmid containing
either the STAR, the trigger or both activators on the same plasmid. The obtained endpoint
fluorescence measurements show a similar behaviour of the AND-gate in vivo and in vitro
(Fig. 2.10 A). A slight activation of the gate when only trigger 2 is present was observed, i.e.,
the transcriptional leakage observed in silico and in vitro occurred as well in living cells. This
indicates that the use of TX-TL as a prototyping platform is not only beneficial for screening
various circuit implementations, but can also be used to analyse more finely the effects of
single part behaviour.
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Fig. 2.11 STARs and toehold switches characterisation for five additional single components. A)
Dose-response curves of sfGFP production rates for STARs 5, 6, 8 in TX-TL. B) Dose-response
curves of sfGFP production rates for toehold 1 and 3. DNA-encoding STAR or trigger activators are
titrated in presence of 2 nM of regulated sfGFP plasmid. Rates were obtained by calculating the slope
in the linear regime of each time-course trace. C) Corresponding relative fluorescence intensities
between in vivo and in vitro for seven single parts. Errors bars represent the standard deviation of
three independent experiments, for in vitro and in vivo data.
2.2 Optimising RNA-based Logic Gates
2.2.1 Additional Parts Characterisation
The prototype gate based on STAR AD1 and toehold 2 showed potential for proper func-
tionality in TX-TL and in vivo, I sought next to create a collection of gates made of various
STAR and toehold parts. Multiple studies have shown that combining single components
may result in unwanted co-folding or context effects, challenging the implementation results
of assembled RNA-parts [71, 48]. However, STAR and toehold components are available
as orthogonal matrices of numerous parts, and are still under active investigation for further
improvements. [77, 20]. As the relatively high OFF-state of the STAR AD1 component was
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Fig. 2.12 In vivo measurements of endpoint fluorescence for each single part, either toehold (1, 2, 3)
or STAR target (5, 6, 8), in presence (+) or absence (-) of their cognate or orthogonal trigger or STAR
antisense. Error bars correspond to the standard deviation of three independent measurements.
identified as the source of the consequential translational leakage in the previous section, I se-
lected three newly engineered STARs with lowered OFF-levels (STAR 5, STAR 6, STAR 8).
In addition, I chose two other high performing toehold switches (toehold 1 and toehold 3) in
order to increase the diversity of the gate library. The context-effect of the toehold sequences
could therefore be studied as well, as the diversity between them is far greater than the one
among the STAR library. Indeed, one current disadvantage of the STARs, at least for the
best performing ones, is that they are built upon the same terminator sequence, which could
be a potential source of cross-talk in multi-layer circuits. Those five RNA single activators
were tested under the same conditions in TX-TL as the initial parts AD1 and toehold 2. The
corresponding dose-response curves of the sfGFP production rates are plotted in Fig. 2.11.
Like previously seen with AD1 STAR and toehold 2, a similar dose-response behavior is
observed i.e. less trigger plasmid is needed to activate the toehold than STAR plasmid is
needed to activate the STAR target. sfGFP production rate is maximal for 3 nM to 5 nM of
trigger-encoding plasmid and for 15 nM to 20 nM of STAR-encoding plasmid. Importantly,
the OFF-level in the absence of the activator STAR DNA (5,6,8) was lower than the one
from STAR AD1, suggesting those parts will likely have a better transcriptional tightness
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Fig. 2.13 Characterisation of logic AND-gates with TX-TL time course reactions. A) Pre-screening
in TX-TL reactions of RNA-based gates composed of a cross design of three toeholds (1, 2, 3)
and three STARs (5, 6, 8), for nine gates. The black shaded regions correspond to the standard
deviation over three independent reactions. Colored lines correspond to the average measurement
over those replicates, according to the presence of either trigger-encoding DNA or STAR encoding
DNA or both. The fold-range is computed as the difference between the active state (both trigger and
STAR are present) divided by the inactive state (trigger and STAR are not present), corrected by the
background value of the TX-TL mix. B) Concentration matrix of TX-TL time course reactions for
the sense 6-toehold 3-sfGFP gate (S6T3). Trigger and STAR encoding plasmids were simultaneously
titrated from 0 nM to 7 nM and from 0 nM to 22 nM, respectively.
when combining into AND-gates. The dynamic range increased as well, in particular for the
STAR 6 construct.
An other important criteria of efficient logic devices is the requirement of orthogonal
parts. In the case of the RNA-based AND-gates, it means that the single components can not
activate a different cognate sequence. This was verified in vivo whether the STAR activates
the toehold or if the trigger is able to activate the STAR target. This was not the case for any
of the tested combinations (Fig. 2.12). The toehold 2, however, had a slighter diminished
dynamic range when any of the STAR were present, suggesting some minor activation level
of the toehold strand by the STAR sequences.
2.2.2 Gates Library in TX-TL System
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Based on the single component parts from the previous section, nine different gates have
been engineered by crossing each STAR target with each toehold switch. This was done in
two distinct stages. First, a screening to detect the gates with the best dynamic ranges was
performed. I described this step as a screening phase even though it required the assembly
and sequencing check of each independent plasmid construct, an approach which is not
compatible with a high-throughput design. The constructs could be as well expressed from
linear template by the addition of GamS (see chapter 4). This could be a way to bring this
screening closer to a higher throughput methodology. The limitation of cell-free reactions in
batch-format for screening of high dimensions parameters needs to be noticed as well. Each
construct needed to be tested in a separate well, which is a disadvantage compared to the
possibilities offered by in vivo screening (see also Section 2.2.4).
As the prototype AD1-toehold 2 gate performed best at 15 nM of STAR and 5 nM of
trigger, I chose the same concentrations of activators for testing the nine additional gates in
TX-TL which are :
• S5T1: Sense 5 - Toehold 1
• S5T2: Sense 5 - Toehold 2
• S5T3: Sense 5 - Toehold 3
• S6T1: Sense 6 - Toehold 1
• S6T2: Sense 6 - Toehold 2
• S6T3: Sense 6 - Toehold 3
• S8T1: Sense 8 - Toehold 1
• S8T2: Sense 8 - Toehold 2
• S8T3: Sense 8 - Toehold 3
In a second stage, I performed a detailed kinetics analysis of the selected gate(s).
Fig. 2.13 A displays the resulting kinetics over a period of 5 hours of TX-TL expression. For
every gate, the plateau is reached between 3 and 4 hours. All gates display Boolean function-
ality regarding to the trigger and STAR activator. However, they have various efficiencies
ranging from around 4-fold for the least efficient (S5T2) to 74-fold for the most efficient
(S6T3). Remarkably, S6T3 presents an absolute fluorescence intensity and a dynamic range
almost one order of magnitude above the pool. Most of the gates display a symmetrical
leakage when only trigger or STAR is expressed, except for S6T2, which shows higher
leakage when only STAR is present. This last result can be seen as well as the level of the
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Fig. 2.14 Dose-response comparison of endpoint fluorescence measurements of three different AND-
gates after 4 hours of expression in TX-TL system; from top to bottom: sense 8-toehold 2, sense 6-
toehold 2, and sense 6-toehold 3.
single components in figure 2.12 where toehold 2 show some slight leakiness when STAR 6
was present.
Despite this last fact, correlation between gate performance and part composition has not
been clearly identified. My assumption was that for all constructs, the final fluorescence level
could only be as high as the least efficient component of the gate, i.e. the STAR target or
toehold switch. In other terms, the level of activated mRNAs from the gate constructs could
not exceed the level from the single STAR or toehold switch composing this gate.
To a certain extent, it can be observed for most of the gates. For instance, the gate S5T3
has the lowest fluorescence value – and is based on the two single components with the
least efficient sfGFP production rate (target 5 and toehold 3, cf Fig. 2.11). However, the
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S6T3 gate is a remarkable counter-example as the high yield of target 6 is not diminished
by the presence of the toehold 3 component. In order to look into more details about the
functioning of this gate, I performed extensive kinetic measurements for S6T3 with similar
concentration conditions as for the initial gate AD1-toehold 2 (see figure. 2.13 B). Initial
screening concentrations were close to the optimal expression level, which were found to
be 2 nM of trigger and around 9 nM of STAR. To assess the qualitative disparity among the
gates’ dose-responses, I performed kinetic measurements for two additional screened gates.
The results are shown in Fig. 2.14. Compared to S6T3, the fluorescence levels were either
intermediate (S6T2) or very low (S8T2). Overall, the qualitative shape remained similar. The
initial screening concentrations were again near the maximum sfGFP-expression. A decrease
in sfGFP fluorescence is observed when both activators are present in high concentration.
This may be due to the toxicity effects reported for high DNA concentration in TX-TL [7].
Resource competition is critical in TX-TL where the energy supply is not replenished. A
relevant experiment to test this hypothesis would be to run the gates in the nano-reactor,
where resources can be replenished to overcome fast energy consumption by the activator
encoding plasmids (see chapter 4).
Fig. 2.15 Computational dose-response of the S6T3 gate after 180 minutes of expression in TX-
TL systems. Experimental data are represented by the black dots, and the variance represents the
standard deviation over three replicates. The model data was rescaled by the factor 80 to visualize the
qualitative comparison.
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Monitoring the transcription process would add some precious insights to enhance our
understanding of the system’s state. One advantage of the RNA-based regulatory system
presented here is that the sfGFP 3’ untranslated region (UTR) is not occupied by any
regulating sequence and can therefore be functionalised with a fluorescent reporter aptamer
[58]. Malachite Green Aptamer (MGA) can specifically bind to malachite green (MG) dye
and induces it to emit far-red fluorescence signals. I used the MGA construct containing 4
tandem repeats (4x MGA) derived from the work of Yerramilli and Kim [134], which show
that placing tandem of MGAs increase the signal to noise ratio (SNR) in living cells. The 4x
MGA array was cloned into the 3’ UTR of the the S6T3-sfGFP gate. Fig. 2.18 displays the
kinetics results of the simultaneous transcription and translation processes. The resulting data
are in agreement to what is expected from the mechanistic gate system. MGA signal remains
at an undetectable level when the gate is not induced by the STAR or the trigger, or induced
with the trigger alone. The transcription signal increases quickly in the two first hours when
the gate is induced by the STAR alone, but no translated sfGFP is observed. When both
STAR 6 and trigger 3 are present, the sfGFP increases until reaching a plateau around 5
hours, as observed previously. After reaching a production peak 1 hour after the start of
the reaction, the mRNA level decreases in the TX-TL system as the degradation rate of the
mRNA exceeds its production rate. Those results are in agreement with similar expressed
constructs reported in the literature [79]. Finally, the production rate of the gate mRNA
may be stronger when the two activators are present compared to the STAR alone, which
would suggest a synergistic effect of those activating sRNAs, but the standard deviation
of the mRNA signals are not different enough to fully support this hypothesis. A deeper
characterisation about the MGA implementation in cell-free systems can be found in the next
chapter.
Applying the ODE modeling framework to some additional gates, similar results as
for the prototype gate were obtained, i.e., rough qualitative agreements which are helpful
to guide the users to predict the dose-response concentrations. However, the quantitative
agreement was mostly not achieved, especially for the S6T3 gate where a clear synergistic
effect takes place that cannot be captured by the composition of the individual models (see
Fig. 2.15).
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Fig. 2.16 MFE secondary structures computed with NUPACK online webserver. The nine AND-gates
are shown in presence of their cognate STAR binding activator. The analysis tool was used with the
following parameters: 37 °C, 0.0 M Mg2+, 1.0 M Na+, two RNA strands. The MFE structure is the
structure of the ordered complex (Gate + STAR activator) which has the minimal total free energy.
Details of the the equilibrium base-pairing properties computed by NUPACK are explained in [136].
Finally, I investigated if in silico folding simulations could explain the difference of the
sfGFP production between S6T3 and the other gates. Free energies of the RBS regions
were computed for a range of sub-optimal structures (Fig. 2.17), showing comparable results
for gates with the same toehold part. Minimum Free Energy (MFE) structures of the gates
complexed with their STAR cognates are displayed in Fig. 2.16. One can observe independent
folding of the STAR and toehold secondary structures. The toehold component was not
disrupted by the upstream spacer and STAR target terminator. The RBS-calculator tool
























Fig. 2.17 Free Energy of the complexes RBS-linker regions. A) Mean Free Energies of the RBS-linker
regions for a range of suboptimal structures. All suboptimal structures in an energy gap of ∆G = 2.5
kcal/mol have been computed with NUPACK’s subopt method. The means are calculated over the
remaining suboptimal structures. Error bars: one standard deviation. B) Schema of the RBS-linker
region for which the free energies are shown.
[99] was used to analyse out-of-frame upstream start codons, but no difference between
gates sharing the same toehold sequences was detected. I suspect that the exceptional S6T3
performance is due to the co-folding effect of the gate sequence on the sfGFP mRNA, which
either affects the translation process or the mRNA stability [29].
2.2.3 Dose-response Matrices Comparison
To further assess the behaviour of S6T3, I compared the traces corresponding to the most
efficient concentrations (9.4 nM of STAR/2 nM of trigger) with a positive control that
contains only a very strong RBS in its 5’ UTR. As shown in Fig. 2.19 A, fluorescence
intensity between the two constructs shows a similar order of magnitude, even though the
plateau phase of S6T3 is reached one hour earlier. We computed the time derivative of the
linear phase (Fig. 2.19 B) and did not observe a significant difference of the sfGFP production
rate. This indicates that the translation efficiency of the S6T3 construct is near its optimum.
This suggests that the observed earlier plateau is likely an issue of energy limitation related to
the transcriptional burden associated with the presence of plasmids encoding the activators’
RNAs. However, the depletion effect is small as both fluorescent values end up on the same
order of magnitude. We found this result to be in agreement with previous experiments
























































































































































































- STAR 6 / - trigger 3 + STAR 6 / - trigger 3
- STAR 6 / + trigger 3 + STAR 6 / + trigger 3
Fig. 2.18 Transcription and translation monitoring of the S6T3 gate. A) Scheme of the MGA-4x
tandem located in the 3’ UTR of the gate construct. The tandem of MGAs is transcribed upon the
activation of the transcription by the STAR activator. B) TX-TL time-course reactions containing
2 nM of S6T3-sfGFP plasmids, in presence or absence of STAR, trigger or both activators. Green area
represent the sfGFP fluorescence and red area, the MGA fluorescence level. Black lines represent the
mean of the replicates, while the shaded regions represent standard deviation of those replicates (n =
3).
and model simulations of the influence of non-coding RNA transcription on the translation
efficiency in TX-TL [109]. I then replaced sfGFP with dTomato, a red fluorescent protein, to
compare the behaviour of the gate with a different downstream coding sequence. Similar to
sfGFP, the order of magnitude of the fluorescence is comparable after 15 hours. However,
the production rate of dTomato regulated by S6T3 is about half of the unregulated one. The
dTomato sequence greatly varies from sfGFP (43.9% similarity score), and it has been shown
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that the folding of the mRNA as well as the codon context can influence protein expression
[21].
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Fig. 2.19 Comparisons between the S6T3 gate and unregulated fluorescent reporters. A) and C) Fluo-
rescence time courses of TX-TL reactions containing either 2 nM of DNA encoding sfGFP/dTomato
with no RNA regulation, or with 2 nM of S6T3 gate in presence of 5 nM of trigger 3 and 15 nM of
STAR 6 plasmids. Black lines represent the mean of the replicates, while the shaded regions represent
standard deviation of those replicates (n=3). B) and D): Average sfGFP/dTomato production rates
computed according to the data in the black boxed region from A and C, respectively.
Co-expression of protein in TX-TL seems to impose a heavier burden on resources
consumption compared to the co-expression of non-coding RNAs. For instance, Shin et
al. [106] reported a decrease of about 12-fold between the sfGFP production controlled
by σ70 and an AND-gate based on the enhancer protein Nrtc and σ54. Furthermore, STAR
and trigger activators are considerably faster than protein activators, which require longer
transcription, as well as supplementary steps (translation and maturation). This observation
agrees with our expectation to obtain quick logic modules, notably faster than their protein-
based counterparts [19]. The time delay of the circuit, defined as the time necessary to
observe a detectable sfGFP signal, was about 15 minutes in this experiment. The response
time of the P54-based AND-gate was found to be around 30 minutes in TX-TL, therefore
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twice as long as the time required by S6T3. Takahashi et al. [120] have found even more
striking evidence for faster signal propagation with about 5 minutes per step of a RNA-based
cascade in TX-TL against 140 minutes as measured in vivo [46].














































































Fig. 2.20 Implementation of the RNA-based gates in vivo. A) Fluorescent measurements of the nine
newly combined AND-gates in E. coli. The different colors indicate controls without any activators,
with only STAR or only trigger. Green bars represent experimental measurements in presence of
both STAR and trigger activators. Numbers with * indicate the fold range computed by the ratio
between the activated gate and the signal without any activators. Error bars correspond to the standard
deviation of three independent measurements. B) Corresponding relative fluorescence intensities
between in vivo and in vitro for ten RNA-based gates.
2.2.4 In vivo Implementation
Performance Comparison
Fast prototyping of synthetic circuits in vitro often aims to transfer the selected candidates into
living organisms. E. coli TOP10 cells were transformed with two plasmids, one containing
the AND-gate controlling the sfGFP-reporter and the other containing one or both activators.
Endpoint fluorescent measurements are shown in Fig. 2.20 A. The nine gates show a very low
OFF-state in the absence of either STAR RNA or trigger RNA. In the presence of one RNA
activator the sfGFP fluorescence increases only between 3- to 10-fold. If both activating
RNAs are present, the reporter fluorescence goes up by more than 50-fold. Comparing
the in vivo to the in vitro measurements, it is possible to see that both measurements are
40 Engineering AND-logic Gates Based on Heterogeneous RNA Regulators
in good agreement with each other (Fig. 2.20 B). The S6T3 gate has by far the highest
ON-state in both the TX-TL and the E. coli measurements (614-fold). Those results add a
supplementary evidence to the list of demonstrated correlation between cell-free-based and
in vivo measurements, ranging from the characterisation of single parts [14, 101] to complex
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FL1-A :: GFP 510-A
Sample Name Subset Name Count Median : FL1-A
s6t3_SGFP_88_noactivators_1.fcs gfp gating 10222 268 
s6t3_SGFP_88_activators_2.fcs Active cells 10875 291366 
10 2 10 3 10 4 10 5 10 6 10 7
FL1-A :: GFP 510-A
Sample Name Subset Name Count Median : FL1-A Median : FL1-A
s6t3_SGFP_54_noactivators_2.fcs gfp gating 10794 283 283 
s6t3_SGFP_54_activators_3.fcs Active cells 13176 225665 225665 
1087x 797x
S6T3_88 S6T3_54
102 103 104 105 106 107 10 103 104 105 106 107
S6T3 mutant 8 S6T3 mutant 54
Fig. 2.21 Randomised spacer in S6T3 led to mutants with enhanced dynamic ranges. A) Design of the
randomised spacer between the target STAR and the toehold regions. Examples of sequenced mutants
are shown in the frame with corresponding secondary structures computed with the RNAfold package.
B) Flow cytometry analysis of the two selected mutants, S6T 3−54 and S6T 3−88 with enhanced
dynamic ranges. Fold-change is computed as the normalised ratio of the activated population median
(green area) with the unactivated population median (grey area).
Spacer Analysis
A remaining question which was not investigated through the previous designs presented
in this chapter is whether the spacer region between the two regulatory RNA elements
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has an influence on the genetic expression of the combined gate. I have shown in section
2.2.2 that traditional secondary structure algorithms do not predict any binding of critical
sequences (STAR terminator or toehold stem) to the spacer region. However, some of the
gates presented some internal base-pairing between the spacer and the trigger-binding region.
I wanted to assess if this sequence region critically influences the gate efficiency. I chose the
best performing S6T3 gate to study this question since it possesses the highest dynamic range,
increasing the chances of observing sequence-dependant variations. A library based on the
S6T3-sfGFP template was generated by inserting ten randomised nucleotides between the
uradine stretch of the STAR terminator and the the beginning of the trigger-binding region of
the toehold switch. The pool was analysed in presence and absence of the co-activators in E.
coli with FACS measurements. 100 sequences were sorted out and selected after gating on
the criteria to belong either to the highest, medium or lowest fluorescence pool. Sequencing
analysis was then performed and secondary structure computed for each of them. Two of
the most occurring sequences (54 and 88) in the high pool and with the lowest occurrences
in the low and medium pool were re-transformed and analysed with FACS (figure 2.21).
The overall dynamic ranges of those gates increased compared to the wild-type S6T3 (797-
and 1087-fold). This could be attributed to the lowered OFF-state while the ON-state level
remained similar to the wild-type S6T3. The presence of the spacer #54 and #88 seem to
have contributed to the independent processing of each gate component. This is supported by
the secondary structures where nucleotides of the spacer region do not form any base-pairs
with neither the STAR or toehold regions.

Chapter 3
Functionalising Cell-Free Systems with
CRISPR-Associated Proteins
Preparation of E.coli-based cell-free extracts (CFEs) has been thoroughly described in the
literature and many parameters of the protocol can be finely tuned to achieve different
yields according to the gene expression context. For instance, expressing genes from a T7
promoter has been shown to work more efficiently in lysates in which the run-off reaction
has been either skipped or shortened. The run-off reaction designates the step where the
lysate is incubated at 37 °C to free the mRNA from the processing ribosomes. Inversely,
expressing genetic constructs from an endogenous E. coli promoter requires run-off reaction
lasting around 80 minutes. Sometimes, minor differences in the protocol steps have been
linked to increased yield variances between batches and can therefore be a source of concern
for achieving reproducible results. One part of the work presented in this chapter was to
leverage the protocol steps found in the literature in order to achieve robust and reproducible
cell-extract production in our laboratory. The second part focuses on the production of
recombinant proteins in the cells, bringing specific functionalities to the resulting cell-
extract. So far, only few reports demonstrated the ability to pre-expressed certain proteins
or precursors while maintaining a high TX-TL activity in the produced lysate. In this thesis
chapter, I studied various parameters of the cell-extract protocol as well as the expression
vector in the chosen E. coli strain, and established a clarifying methodology for producing
functionalised cell-free systems with two different CRISPR-associated proteins, dSpyCas9
endonuclease and Csy4 endoribonuclease.
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3.1 A Wide Range of RNA-guided Nucleases
CRISPR-associated systems have become established tools in biological engineering. They
were initially characterised as adaptive immune system that protects prokaryotes from foreign
genetic materials, such as viruses. Indeed, a vast majority of archaea and half of bacteria
harbor one or several CRISPR loci which are highly repetitive genomic regions composed of
a series of nucleotide repeats separated by unique spacer sequences [2]. CRISPR loci can
often be found co-expressed and co-adjacent to CRISPR-associated (Cas) genes, which are
essential to the immune response. The unique spacers share partial genetic matches with
bacteriophage genomes and plasmids. The CRISPR loci can thus be seen as a chronological
record of the encountered viruses by the cell and its ancestors. CRISPR loci possess a
large difference of repeat numbers: from 2 up to 250 and can be found either as a single
CRISPR locus in many prokaryotes, but some can have dozen more [113]. Repeat sequences
contain typically between 28 and 40 nucleotides in length, and spacer sequences go up to 72
nucleotides [2].
The CRISPR-Cas mediated immunity can be divided into three main steps [97]. The first
step leads to the integration of newly encountered spacers in the CRISPR locus. During the
second step, the system is translating the necessary Cas genes and transcribing the CRISPR
array into a long precursor CRISPR RNA (pre-crRNA) which is processed into mature
crRNA by Cas proteins and co-factors. The final step is the targeting of the matching nucleic
acid sequence and its destruction by the complex formed by crRNA and Cas proteins.
CRISPR-associated systems have been re-engineered for many applications ranging from
circuit regulation to genome engineering. Targeting CRISPR-Cas nucleases to cleave or bind
to a chosen DNA sequence involve solely the co-expression of a non-coding sgRNA, which
includes a spacer sequence needed for base-pairing with the sequence of interest [76]. Only
few constraints exist regarding the design of the spacer: the main one requires the spacer
to be flanked with a pre-determined protospacer-adjacent motif (PAM). Many different Cas
proteins have been characterised and new ones are still discovered up to now. They are
categorised according to the structure and function of Cas protein. The CRISPR-Cas systems
are categorized into two classes (class I, class II), and subdivided into six types (type I–VI).
Class I includes type I, III, and IV, and class II includes type II, V, and VI. Type I, II, and
V systems are able to target and cleave DNA, the newly found type VI can target and edit
RNA, and type III can edit both DNA and RNA. These types are further sub-divided in
30 subtypes with specific activities such as cleavage or degradation of the target, diverse
PAM sequences recognition, processing of their own sgRNA arrays, and different levels of
off-targets cleavage [76].
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The method proposed in this chapter enables the enhancement of TX-TL systems with
two pre-expressed CRISPR-associated nucleases: Csy4 or dCas9. They are among the
most common Cas nucleases used in the circuit engineering field, but this method could be
easily extended to any CRISPR-associated systems. Many CRISPR-Cas systems are not yet
fully characterized and/or adapted for use in biotechnology, and TX-TL platforms may be a
platform of choice for characterising and screening their associated components, as recently
demonstrated by Wandera et al. [126].
3.2 Preparation of Cell-free Extracts
3.2.1 E. coli "Wild-Type" Extract Preparation
The general CFE protocol used in this work is based on the BL21 E.coli Rosetta™ 2 strain
and is closely related to the protocol described from Silverman et al. [111] with some slight
adaptations. More details about the preparation are available in the method chapter (section
6.1.1). The dialysis step is also omitted as it did not improve the yield of the CFE (data not
shown). Table 3.1 describes the different CFE protocols developed during the last decade
as well as the first one originally reported from Zubay [138]. The lysis and post-lysis are
the steps with the high variability of parameters. Interestingly, it has been shown that the
promoter-driven systems used to express genetic constructs in the CFE are step-dependent
and strain-dependent. For instance, expressing a gene driven by a T7 bacteriophage promoter
requires skipping the run-off reaction [63] for the BL21 strain. In this thesis, I focused on
expressing RNA-circuits driven by the endogenous E. coli RNAP, and the protocol parameters
for the lysis and post-lysis steps have been chosen accordingly.
To report on the yield of the CFE, a standardised control plasmid is used. It consists of a
strong σ70 promoter followed by a 5’ UTR containing a stability hairpin, a strong RBS, a
gene coding for sfGFP, the MGA 4x tandem, and the T500 terminator (Fig. 3.2 A).
Lysis step
The sonication energy and the corresponding proceeded volume (in which the cell’s pellet
is resuspended) have been shown to be critical parameters for the yield of the CFE. Two
specific volumes were used for the production of different extracts used throughout this thesis,
depending on the initial amount of cultivated cells. 1 mL and 0.7 mL were used with an
optimal sonication energy of 700 J and 500 J. This step is likely the one prone to most of the
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Table 3.1 Summary of critical step differences between CFE preparation protocols. The red cells
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method















80 min 80 min none for BL21 80 min 80 min
dialysis 18 h 3 h none 3 h none
flash freeze none none before lysis before lysis none
yield variation between batches due to the human-handling insertion of the sonication probe
in the resuspended pellet. To improve the consistency of the lysed CFE, an homogeniser
could be used at this step to process large cultures, remove insoluble components and diverse
cells debris [63]. A cooling time of 10 seconds for every 10 seconds of sonication were used
in all cases. This parameter has previously been shown to not have an impact on the final
yield.
Effect of the cells harvest time on the CFE activity
The machinery composition of the cells is affected by the time of harvest, which ultimately
influences the yield of the CFE [63]. CFEs have shown functionality for a wide range of
cells harvest times, from the exponential growth phase up to the saturation phase. The
TX-TL enzymes are harvested in a more active state during the early exponential phase, but
the increased cell mass obtained with higher OD600 compensates for the loss of enzymes
activity [34]. In this work, I reproduce the results from Kwon and Jewett [63] with the
standardised plasmid reporting for both mRNA transcription and protein production. E. coli
BL21 rosetta 2 cells were grown to OD600 1.9, 2.5, 3.5, 4, 4.5, 5.2, covering the range of
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Fig. 3.1 TX-TL time-course reactions in CFEs produced at different times of cells harvest. Expression
of 5 nM of plasmid Pr-sfGFP-MGA4x-T500. sfGFP fluorescence has a green shaded green region
corresponding to the standard deviation of 3 replicates. MGA fluorescence has a shaded red region
corresponding to the standard deviation of 3 replicates. Average of time traces are denoted in black.
mid to late exponential growth. For each OD600, an independent crude lysate was processed
and supplemented with energy buffer (see methods for a detailed explanation of the energy
buffer preparation). The CFE transcriptional and translational activities were constant over
all OD600 (Fig. 3.1). The best yields were obtained for ODs600 3.5 and 4.2, and the lowest
yied was for OD600 2.1, confirming the trend published previously by Kwon and Jewett
[63]. The mRNA level showed a much greater variation for any OD600, with a maximum at
OD600 3.5 and a minimum for OD600 2.1. Interestingly, mRNA signal reaches its maximum
intensity level later in the lowest OD600 (around 6 hours) and earlier in the other ODs600
(between 4 and 5 hours) . The variation in the qualitative and quantitative states of the E.coli
machinery, i.e polymerases, ribosomes or RNAses, resulting from the harvest at different
OD600, could explain those kinetic differences.
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Fig. 3.2 Influence of the pre-expression of proteins in BL21 rosetta™ 2 cells on the resulting CFE
efficiency. A) The standard plasmid reporter Pr-sfGFP-MGA4x enables simultaneous monitoring of
the transcription and translation production. Four different CFEs are considered here: the wild-type
(WT), and three CFEs pre-expressing Csy4 (grey color), dSpyCas9 (yellow), or mRFP1 (black).
Examples of TX-TL time-course reactions for the WT, Cys4 and dCas9 CFEs expressing 1 nM of
reporter plasmid. B) sfGFP (left) and mRFP1 (right) yields of the CFEs for different ODs600 (1 nM of
reporter plasmid). C) Influence of the sonication energy on the CFE performance for mRFP1 and
dCas9 CFEs (1 nM of reporter plasmid). D) Pr-sfGFP-MGA4x plasmid titration in three CFEs, with
sfGFP fluorescence endpoints on the left and MGA fluorescence endpoints on the right.
DNA titration
Every CFE batch needs to be tested with a range of concentrations of the reporter plasmid.
Indeed, the quantity and quality of the lysate machinery can variate considerably between
CFE batches, which ultimatelty influences the DNA concentration boundaries suitable for
circuit prototyping. (Fig. 3.3 A).
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Fig. 3.3 DNA and maltose concentrations influence transcription and translation performance in
CFE. A) TX-TL time-course reactions for 1, 2 and 4 nM of Pr-sfGFP-MGA4x-T500 plasmid. B)
TX-TL time-course reactions for 0, 4, 8 and 12 mM of maltose. sfGFP has a shaded green region
corresponding to the standard deviation of 3 replicates. MGA fluorescence has a shaded red region
corresponding to the standard deviation of 3 replicates. Mean of fluorescent traces are denoted in
black.
ATP regeneration system
In this work, the CFEs are supplemented with an energy regeneration system based on
3-phosphoglycerate (3-PGA). 3-PGA increases ATP regeneration as a precursor of the
tricarboxylic acid cycle (TCA) [119]. Recent update of the protocol suggests the use of the
maltose metabolic pathway for recycling inorganic phosphate (Pi), by-products of the protein
synthesis, through the glycolytic pathway, which could be easily implemented due to the
endogenous enzymes present in the crude extract [10]. In accordance with the literature,
maltose was titrated between 0 and 13 mM in the CFE and resulting fluorescent time-course
traces for translation and transcription are displayed in Fig. 3.3 B. Contrary to what was
stated by Caschera and Noireaux [10], the protein yield decreases with the increase of maltose
concentration in our CFE. However, the mRNA production level increases linearly with the
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maltose concentration. These counter-intuitive results could indicate a complex inter-play of
resource usage in the CFE. The maltose may shift the resource usage towards the RNAPs
at the expense of the ribosomes. In a context of RNA-circuit prototyping in a cell-free
environment, it is interesting to notice that TX activity could be enhanced through a simple
maltose supplementation.
3.2.2 Pre-Expressing Csy4 and dSpyCas9 Proteins
Characterisation of the augmented CFEs
The CFE protocol was modified by transforming the BL21 Rosetta™ 2 strain with a second,
high copy, ampicillin-resistant plasmid. Every step of the protocol was the same as the wild-
type (WT), except that the cells had to be cultivated with both ampicilin and chloramphenicol
antibiotics in the medium. The growth kinetics for the WT, Csy4 and dSpyCas9 were
obtained by monitoring OD600. The second plasmid expressing the recombining protein
did not have a dramatic impact on the growth kinetics or doubling time (data not shown).
Both Csy4 and dSpyCas9 CFEs were tested for different ODs600, similarly to the experiment
performed in the last section for the WT strain. The sfGFP endpoint measurements for 1
nM of control plasmid are displayed in Fig. 3.2 B and show a robust consistency between
CFEs. The optimum yield is reached between OD600 3 and 4 and the lowest yield are found
between OD600 1.8 and 2.5, consistent with previous experiments performed by Kwon and
Jewett [63]. Kinetic fluorescent traces for the three CFEs in presence of 1 nM of control
plasmid are shown in Fig. 3.2 A. Kinetics and yields were similar in those three systems,
with sfGFP and MGA levels reaching similar values after 10 hours of expression. The mRNA
signal reaches its highest level between 3 and 5 hours of expression. The Csy4 CFE exhibits,
however, a slight delayed expression, but this variation of kinetic speed is likely due to the
high variability of CFE batches, a known problem in the CFE field [105]. The reporter
plasmid was titrated between 1 to 20 nM in the three CFEs. Similar saturation curves were
found in the three systems for both mRNA and protein expression (Fig. 3.2 D) with highest
yields found at 20 nM of plasmid, one order of magnitude higher than the yields obtained
with 1 nM. Calibration curves were performed in order to quantify both mRNA and protein
levels expressed by the CFEs. For the highest concentration of Pr-sfGFP plasmid, yields
between 1 and 10 µM of sfGFP are reached in the three extracts, showing similar performance
than the CFE protocol from Silverman et al. [111]. Correspondingly, mRNA level was found
to reach 250 nM to 900 nM (corresponding calibrations can be found in Fig. 6.1).
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Quantification of the pre-expressed protein
In order to quantify the concentration of pre-expressed proteins obtained in the final lysate,
either for Csy4 or dSpyCas9, I produced a fourth CFE based on the constitutive production
of mRFP1 with the J23108 promoter. sfGFP expression in the mRFP1 CFE follows a
similar trend than the three other CFEs, indicating the correct functionality of the CFE.
A first experiment in which the lysates were processed at various ODs600 did not show
any significant variation of the mRFP1 level (Fig. 3.2 B). Sonication energies were varied
between 300 and 500 J in a second experiment. Lysing the cells with different energies could
indeed lead to different concentration of proteins in the lysate. An increase in sfGFP yield
was observed with the increase of sonication energy for the mRFP1 and dSpyCas9 CFEs,
similarly as previoulsy decribed by Kwon and Jewett [63]. However, the sonication energy
was not critically influential on the level of mRFP1 (Fig. 3.2 C). Finally, a calibration curve
was measured for mRFP1 fluorescence (See Fig. 6.1) and the mRFP1 quantity was found to
be in the range of 30-50 nM in the final CFE. However, the quantity of dSpyCas9 and Csy4
cannot be directly inferred from those data, but it may give a rough estimate. For instance, I
would expect dSpyCas9 to be several times less abundant since its coding gene size is about
4236 bps versus only 672 bps for mRFP1. However, Csy4 has a very similar coding size as
mRFP1 with 561 bps and is expected to be in a similar concentration in the final CFE.
3.3 Assessing the Functionality of the CRISPR-associated
Proteins
After having shown that the enhanced Csy4 and dSpyCas9 CFEs have a similar efficiency
as their WT counterparts, the next step is to characterise the qualitative effects of those
nucleases for the prototyping of synthetic circuits in TX-TL.
3.3.1 Csy4 Endoribonuclease as a Tool for RNA Processing
Csy4 or (Cas9f) is a endoribonuclease found in Pseudomonas aeruginosa, which recognises
and cleaves a specific 28-nt long RNA sequence (Fig. 3.5 A). It was found to help the
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Fig. 3.4 Scheme mechanism of dSpyCas9. A) dSpyCas9 prepackaged in TX-TL. A plasmid expresses
a small guide RNA, which after assembly with dSpyCas9, enables the blockage of the transcription
elongation at the targeted location. B) The four different sgRNAs designed in this work target diverse
locations on the reporter plasmid. They target regions from the endogenous promoter sequence up to
the 3’ end of the GFP. The two schemes indicate the expected behaviors for the mRNA and protein
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Fig. 3.5 Scheme mechanism of the endoribonuclease Csy4. A) Csy4 prepackaged in TX-TL system.
Example of DNA construct expressing sfGFP with a 5’ UTR and a Csy4 cleavage hairpin upstream
to the start codon. Upon cleavage by the Csy4 endoribonuclease, the 5’ UTR mRNA and the sfGFP
coding mRNA are separated. B) Design experiment where 5’ UTRs of various strengths are tested in
presence (right curves) or absence of Csy4 protein (left curves).
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transcribed processing of the long repetive elements belonging to the CRISPR locus. Recently,
Qi et al. [96] demonstrated the use of Csy4 endoribonuclease in bacteria for improving
the processing of synthetic regulators in a variety of circuit implementations. In order to
test the efficiency of Csy4 as a RNA-processing tool in our TX-TL platform, a similar
context experiment as the one described by Qi et al. [96] was performed. Briefly, various
5’ UTR sequences were cloned upstream to the sfGFP, replacing the original 5’ UTR used
in the standarised reporter plasmid. These UTRs have been characterised with a range of
translational strengths, leading to variable amount of translated proteins. However, after
insertion of the Csy4 hairpin upstream to the gene, the downstream 5’ UTR should lose
its influence on the translational efficiency upon cleavage by the Csy4 endoribonuclease.
Diverse UTRs processed by Csy4 should therefore lead to a similar, normalised GFP signal
(Fig. 3.5 B).
5’ UTR regions can be cleaved with Csy4 in TX-TL
In order to assess their respective strengths, the six chosen 5’ UTRs were tested in the WT
CFE at diverse ODs600 (Fig. 3.6 B). The 5’ UTR sequences were chosen from the work of
Evfratov et al. [32]. The data show a wide range of sfGFP yields, and follow a consistent
trend between CFEs of different ODs600. Next, I selected two UTRs elements harboring a
large strength difference (Ion-UTR and RpvI-UTR) and performed kinetics with a set of
control conditions (Fig. 3.6 A). First, the difference in sfGFP yield was verified in the WT
CFE with 1 nM of constructs containing the Csy4 hairpin. 1 nM of constructs without Csy4
hairpin were also tested in the Csy4 CFE. A large difference in sfGFP yield was observed in
this case as well. Finally, the constructs containing the Csy4 hairpin were tested in the Csy4
CFE, leading to a similar yield in sfGFP for the both UTR constructs. Those results strongly
suggest the effective processing of the 5’ UTRs by Csy4 in TX-TL. Interestingly, in these
experiments, the mRNA output was found to exhibit a similar pattern as well, even though no
effects related to transcription normalisation was excepted from the Csy4 endoribonuclease.
However, the use of a DNA template at low concentration (1 nM) leads to a weak and noisy
MGA signal, which could easily confound this hypothesis.
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Fig. 3.6 Csy4 can process mRNA in TX-TL systems. Green circle = WT CFE, grey circle = Csy4 CFE.
A) TX-TL time-course reactions of sfGFP and MGA for two different UTR constructs, expressed
either in WT CFE or Csy4 CFE, with and without the Csy4 processing hairpin. B) sfGFP endpoint
measurements of 7 different UTRs in WT CFE from various ODs600. C) Normalised endpoint
measurements for 1 nM of each UTR plasmid in WT and Csy4 CFEs. Three different Csy4 CFEs are
compared, varying in the strength of the Csy4 promoter used. All data are normalised to 1 nM of the
reporter plasmid. D) Measures of dispersion applied to experiments presented in C). The dispersion
statistics are computed for each CFE experiment over all UTRs data (n = 18 in each experiment, with
6 different UTRs and 3 technical replicates for each). SD = standard deviation, iqr = interquartile
range, mad = median absolute deviation, med = median.
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Csy4 efficiency scales up linearly with the strength of the promoter
In order to confirm the results obtained previously, all UTRs constructs with Csy4 hairpin
were compared as endpoint fluorescent measurements in both WT and Csy4 CFEs. Values
were normalised to the reporter control plasmid which does not contain a Csy4 hairpin (Fig.
3.6 C). For the Csy4 CFE produced with the promoter J123108 (strength = 0.5), the UTRs
constructs in WT CFE displayed diverse yields between 0.1 and 2.2 fold of the control
construct, as expected from this short library of 5’ UTRs. When expressed in the Cys4
CFE, the yield of every UTR construct was narrowed down to 0.1 to 0.9 fold of the control
construct. As a complementary negative control, the test of all UTRs in WT CFE with and
without Csy4 hairpins led to a bigger dispersion of yields in both cases (between 0.1 and
2.25 fold of the control construct), validating the effect of Csy4 processing in the Csy4 CFE.
Two additional Csy4 CFEs were made with different constitutive promoter strengths. J23115
and J23107 correspond respectively to a relative strength of 0.15 and 0.34 compared to the
reference J23119. The results are displayed in Fig. 3.6 C. The UTRs containing Csy4 hairpin
expressed a narrower range of sfGFP yields in the Csy4 CFE than the WT CFE. However,
the processing seem to not be as efficient as in the Csy4 CFE with the stronger J23108
promoter. In order to summarise the results, a set of five different statistics of dispersion
are plotted in Fig. 3.6 D for each CFE. The standard deviation, the range, the interquartile
range, the median absolute deviation and the median have reduced values in the three Csy4
CFEs compared to the WT CFE. Remarkably, the values of the selected dispersion measures
decrease along with the increase of the promoter strength. This likely indicates a greater
processing ability when a higher concentration of Csy4 protein is present in the CFE. It also
suggests that Csy4 may be saturated by mRNA and indicates that the processing efficiency
may decrease with an increase of mRNA production.
3.3.2 Characterisation of dSpyCas9 Activity in CFE
In order to assess the pre-expressed dSpyCas9 activity in the produced CFE, four different
sgRNAs were designed with the help of the benchling CRISPR tool. Briefly, the 4 sgRNAs
were selected to maximize the ON-target score and minimise the OFF-target score according
to the model scoring guide by Doench et al. [27]. Three sgRNAs bind in the non-target strand
of the sfGFP coding sequence (5’, middle and 3’ of the gene, denoted as sg-1,-2,-3) while
the fourth sgRNA binds in the J23119 promoter sequence (sg-4). In presence of the sgRNAs,
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Fig. 3.7 dSpyCas9 is an efficient tool for gene repression in TX-TL systems. A) sfGFP time-
course traces of 1 nM of reporter plasmid in presence of 4 different sgRNAs encoding plasmid
(10 nM), expressed in dCas9 CFEs made from different ODs600. The positive control (+) has been
performed in presence of 10 nm of a plasmid coding for a decoy sRNA. B) Heatmaps summarising the
corresponding endpoint fluorescences for sfGFP (green) and maximum fluorescence reached by MGA
(red). Colorbar scales are transformed into the log space for increased visibility (1 = no repression, 0
= total repression). C) sfGFP and MGA time-course traces performed in a WT CFE with the same
concentrations of reporter and sgRNA plasmids. D) sfGFP and MGA time-course traces performed in
a Cas9 CFE of 2 nM of reporter plasmid titrated with sg2 (2 to 10 nM). Black lines represent the mean
of the replicates, while the shaded regions represent standard deviation of those replicates (n = 3).
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the control plasmid should therefore not express the sfGFP since the transcription elongation
is hindered by the complex dSpyCas9-sgRNA located on the DNA template (Fig. 3.4). Both
sfGFP and MGA fluorescent signals are therefore expected to be lowered in presence of
the sgRNA expressing plasmid. First, 10 nM of sgRNA encoding plasmids were tested in
presence of 1 nM of the reporter plasmid in the WT CFE (Fig . 3.7 C). The results show
similar qualitative and quantitative kinetic traces for MGA and sfGFP fluorescences between
the control experiment and the four different sgRNAs. Since no dSpyCas9 is present in the
WT CFE, no inhibition of gene expression is observed. In the following experiments, 10 nM
of plasmid coding for a decoy RNA (AD1) is used along with the positive reporter plasmid
to mimic the resources consumption used by the sgRNA plasmid. the TX-burden imposed by
the sgRNA encoding plasmid could decrease the TL yield, as demonstrated by Siegal-gaskins
et al. [109].
dSpyCas9 is active regardless of the CFE harvest time
Four dSpyCas9 CFEs made from different harvest time spanning from a range of mid to
late exponential growth (OD600 = 2.2, 3.0, 4.1 and 4.8) were used to test the activity of
the four constructed sgRNAs. Results are shown in Fig. 3.7 A. Compared to the positive
control, all sfGFP kinetic traces show a dramatic decrease in fluorescence for all conditions,
regardless of the OD600 or of the sgRNA. This reflects the result obtained earlier about the
quantification of the mRFP1 protein through a similar range of ODs600, i.e. dSpyCas9 is
present in similar concentration in CFEs made from different ODs600. However, the gene
target is less repressed in CFE made from cells harvested at OD600 2.2. This could be
linked to the slower kinetic, characteristic of CFEs made from cells harvested at the early
exponential phase, like observed for the WT CFE in Fig. 3.1. Heatmaps summarising the
corresponding fluorescent endpoints for sfGFP and MGA are displayed in Fig. 3.7 B. Sg1,
sg2 and sg4 display a similar sfGFP repressing strength, and sg3 is the less efficient sgRNA
throughout each OD600. This may be explained by the target of sgRNA 3, located towards the
3’ end of the sfGFP coding sequence, enabling the transcription of a near-to-complete sfGFP
mRNA. The heatmap of the MGA signal, corresponding to the maximum MGA fluorescence
intensity recorded during the time-course reaction, does not show any obvious correlations
between sgRNA targets or ODs600. However, it is consistent with the observation that the
transcription is repressed for all experiments, compared to the positive control. This lack of
more detailed transcriptional information could come from the low level of gene expression,
leading to a low signal-to-noise ratio (SNR) for the MGA signal.
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3.3.3 Applications for RNA-based Circuitry
After having determined the efficiency of the Csy4 processing and characterized the inhibition
strength of the complex dSpyCas9 with various sgRNAs, the next step was to merge those
new synthetic tools for TX-TL system with the RNA-based circuits prototyped in the 2nd
chapter.
Fig. 3.8 Csy4 activity enhances the translational efficiency of the S6T2 AND-gate in TX-TL systems.
A) Scheme of the S6T2-sfGFP-MGA4x construct, with and without the Csy4 hairpin between the
sense 6 and toehold 2 components. B) sfGFP endpoint fluorescence measurements of the two gate
variants in WT CFE (left) and in Csy4 CFE (right) with (blue) and without Csy4 hairpin (green). C)
MGA fluorescence production rate of the two gates in WT CFE (left) and in Csy4 CFE (right) with
(pink) and without (orange) Csy4 hairpin.
Csy4 enhances translation activity of S6T2 in cis-configuration
A direct application of the Csy4 ability to process RNA elements would be to test whether
the system could enhance the RNA-based AND gates. I chose a low efficient gate, S6T2,
from the screening procedure (see Fig. 2.13) and created a variant with the Csy4 hairpin
inserted between the sense 6 and toehold 2 components (Fig.3.8 A). This configuration is
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denoted as "cis-acting" since the three RNA components: sense, Csy4 hairpin and toehold,
influence directly the TX-TL activities of the downstream gene. I hypothesised the Csy4
enhancement would be more obvious in a RNA-based gate with a low efficiency, since it is
likely where RNA co-folding issues arise the most. First, the gates’ dose responses titrated
with STAR 6 and trigger 2 were compared in a WT CFE (Fig. 3.8 B). The dose-responses
show similar landscapes for the sfGFP endpoints, indicating no difference of expression
between the two constructs. This is a negative control used to verify if the Csy4 hairpin
sequence alone could influence the gate, without the processing of the Csy4 protein. The two
gate variants were then expressed in a Csy4 CFE with the same dose-response setup (Fig.
3.8 B). S6-cys4-T2 displays a higher dynamic range (around 10 fold increase) than S6T2
for the sfGFP fluorescence endpoints. Moreover, the fluorescence level remain similar when
the two activators STAR 6 or trigger 2 are absent. This indicates that the enhanced dynamic
range is likely not a Csy4 artefact due to the gate misfolding, which could result in high
TX or TL leakage. Finally, Fig. 3.8 shows the MGA fluorescence rate of the corresponding
experiments in WT and Csy4 CFEs. Interestingly, S6-csy4-T2 displays a higher TX rate
than S6-T2 for concentrations of STAR above 6 nM in both CFEs, suggesting than Cys4
hairpin alone enables a better TX processing of the gate. The observed increased sfGFP
level of S6-csy4-T2 can be attributed to the indirect enhancement of the TL process by the
Csy4 endoribonuclease, since it was not observed in the WT CFE. This experiment also
confirms the capacity of the sfGFP-MGA4x construct to monitor independently both mRNA
and protein level for complex synthetic circuits. In particular, the decoupled TX and TL
dose-responses obtained here confirm the independent activation of TX and TL processes by
STAR and trigger (see section 2.2.2).
Blending of CFEs
Two constructs were assembled in order to combine the computational logic of the S6T3
gate and sg1-dCas9 system. Briefly, in the first construct, STAR6, trigger 3 and sg1 were
assembled in tandem without spacer (I1). In the second construct (I2), a Csy4 hairpin was
inserted between each sRNA sequence (Fig. 3.9 A). The combining logic of those 3 sRNAs
should result into a NOT∧AND type of logic circuit. In other terms, STAR 6 and trigger
3 should act as the AND inputs of the gate, and the sgRNA should act as the logical NOT
complement. Expressing the three inputs from the same genetic layer has multiple aims: First,
it is important to be able to compress information encoding systems into the less possible
space, as the complexity of the integrated circuits increase. Second, Csy4 processing ability
could be useful to improve the processing of such synthetic sRNA operons. Three CFEs


























































Fig. 3.9 Csy4 and dSpyCas9 CFEs can be efficiently combined to enhance the RNA-based toolbox in
TX-TL systems. A) Scheme of the two different input DNA constructs, I1 and I2. I2 contains the
Csy4 processing hairpin, hence once expressed in a Csy4 CFE, the inputs can be processed by the
endoribonuclease. STAR 6 and trigger 3 activate the TX and TL of sfGFP, while the sgRNA 1 inhibits
it. B) Csy4 (grey) and dSpyCas9 (yellow) CFEs mixed to form a "blended" CFE (shaded). Endpoint
fluorescent measurements of sfGFP produced with 2 nM of S6T3 plasmid and 10 nM of either I1,
I2 or ID (control) in different CFEs (colored squares). C) Corresponding detailed kinetic traces for
sfGFP and MGA from the experiment shown in B). Black lines represent the mean of the replicates,
while the shaded regions represent standard deviation of those replicates (n = 3).
were used to test these two constructs: Csy4, dCas9, and a blended CFE made from 0.5 part
of Csy4 CFE and 0.5 part of dCas9 CFE (Fig. 3.9 B). In all CFE experiments, concentrations
of I1 and I2 were kept at 10 nM and concentration of the gate reporter was set to 2 nM.
Results are shown in Fig. 3.9 C and D. In the dSpyCas9 CFE, both I1 and I2 show slight
activation, with similar sfGFP production rates (about 400 A.U. per minute). In the blended
CFE, I1 triggers a similar activation level, likely due to the absence of the Csy4 hairpin. In
presence of I2, no activation is observed, which demonstrates a complete inhibition of the
gate. Additionally, expressing I2 in the blended CFE leads to a similar level of inhibition as
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when expressing the gate in presence of a decoy sRNA (ID). Taken together, those results
indicate that Csy4 and dSpyCas9 could be used in synergy when applied to RNA-based
circuitry to decrease circuit leakage, increase the type of computational logic available, and
increase encoding possibilities for the sRNA inputs.

Chapter 4
Beyond Cell-Free Batch Reactions: From
Steady-State to Stochastic Experiments
4.1 Development of a Nanoliter-Scaled Chemostat
4.1.1 Limitations of the Batch Reaction Format
As shown in the previous chapters and from multiple published studies, genetic and metabolic
networks can be implemented and studied in TX-TL systems. However, in most of the cases,
the complexity of the circuits remains limited to sequential events i.e. genetic cascades, where
the first layer of information activates or inhibits the other layers. It was the case for instance
for the implementation of the RNA-based logic gates where two RNA-activators trigger the
production of sfGFP (see 2nd chapter). Studies demonstrating the in vitro implementation
of auto-catalytic circuits, either encoded as a negative or positive feedback, remain basic
and limited to a couple of interacting species [48]. The implementation of more complex
dynamical circuits is therefore limited by the batch-format in which the cell-free reactions
are expressed. The batch environment of a test tube limits the output of the reaction and the
gene synthesis rate decreases as energy precursors are consumed. The accumulation of by-
products and the associated pH shift have also been shown to contribute to the slowing down
of enzymatic reactions [82]. After a couple of hours, the chemical reactions are therefore at
equilibrium in a batch-tube. Cell-free reaction times have been successfully extended with
diverse strategies like the use of exchange devices of large scale, the semi-batches systems
[114], or at the micrometer scale by expressing the TX-TL system inside vesicles with a
phospholipid membrane in a feeding solution [86, 39].



























Fig. 4.1 Scheme of the transcription-translation rates of a cell-free reaction when performed in a
batch-format (black lines) or at steady state in living cells or in the chemostat (red lines).
These examples have contributed to increase significantly the protein yield of TX-TL
system, which is the main concern of many biotechnology production processes. However,
those set-ups with continuous reaction conditions are not fully adequate for the prototype of
dynamical synthetic circuits such as oscillators or toggle switches. These circuits require
the degradation of intermediate inhibitors products to reset the state of the circuit nodes
when several negative feedback loops are presents. The degradation pathways are extremely
efficient in vivo, where part of E.coli metabolism is placed upon multiple feedback loops [75].
In TX-TL, the protein products accumulate in the batch tube since the proteases are usually in
negligible amount and expressed proteins would require a specific degradation tag. Strategies
to implement active degradation pathways such as the use of ClpXP to specifically target
proteins harboring degradation tags have been investigated and offer promising solutions
[39, 103]. It remains still challenging to implement large genetic networks since active
degradation will be ultimately limited by the energy capability of the batch system and
Clp are ATP-dependent proteases. Recently, Niederholtmeyer et al. [82] have developed
a microfluidic device to overcome those limitations [83]. It consists of a 33-nL reactor
operating at steady-state for an extended period of time where successive dilutions of the
cell-free/DNA mixture occur in discrete steps. The first stage of this project was to implement
a similar device at the BCS laboratory, from the device fabrication to the software operation.
4.1.2 Microfluidic Implementation
Design and Fabrication
For running the TX-TL reactions at steady state, the chip was designed with two layers of
PDMS. The chip design is similar to previous published implementations, in particular the
one published by Niederholtmeyer et al. [82]. However, I down-scaled the reactor volume
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Fig. 4.2 Photography of the microscope set-up for microfluidic experiments. The solenoid valves are
connected to the control layer of the chip. The computer controlling the microscope is not shown.
from 33 nl to 10 nl. The first layer contains the flow channels and the reactor where the
TX-TL system and reactants are flushed with (flow layer). The second layer contains the
control channels and Quake valves [5] connected to the solenoid valves (control layer).
The first version of the chip contained only one reactor. This single reactor design aimed
to facilitate the set-up implementation and configuration, and to minimise the complications
arising from having to manage parallel reactors. One main distinction of my design is that a
pulse width modulation control (PWMC) module was incorporated between the inlets and
the reactor core. This module will enable the generation of a range of desired concentration
inputs by mixing the packages of different inputs at different frequencies [1].
In the single-core version of the chemostat (Fig. 4.3), four inlets are available to connect
the fluids, i.e. DNA, buffer or TX-TL system. These inputs can be controlled independently
by Quake valves, c.g. for opening or closing the corresponding channels. The bypass function
enables the rapid flushing of the reactants in the channel when switching the inputs. The first
peristaltic pump after the PWMC module enables to meter the reactants of different package
size according to the flow rate and frequency patterns of the valves. A second peristaltic















Fig. 4.3 AutoCAD design of the microfluidic chemostat. A) 10 parallel chips can be produced from
the same wafer. B) Close-up of a single chip design. High-height flow channels are in green, control
layer is in marroon, and low-height flow channels are in yellow. (1) 4 inlets connected to the flow
channels, (2) PWMC module, (3) chemostat reactor and imaging position (white circle), (4) first
peristaltic pump, (5) second peristaltic pump, (6) bypass channel.
pump is located inside the reactor and enables the proper mixing of the reactants. The small
volume of the microfluidic reactor requires an active mixing strategy to be completely mixed
within the time-scale of the TX-TL reaction. The reaction ring can be completely sealed
from the external flow channels by closing its inlet and outlet valves.
Two different wafers were used for the fabrication of the flow and control layers. The
fabrication protocols for each layer are described in Table 6.7. Briefly, I used standard
photolitography techniques. The flow layer required the use of two different photoresists, as
the channel heights needed to be lower beneath the valves to close quickly and robustly the
flow channels. Finally, the PDMS chips were fabricated according to standard multilayer
soft litography and the detailed corresponding methods can be found in section 6.1.4.
Microscopy Set-up and Chip Operation
The microscope set-up is described in Fig. 4.4 and the detailed list of the components are
listed in Table 6.12 and Table 6.9. Shortly, the chip was first mounted on a metal plate and
the incubator box was set up at 29 °C. The solenoid valves (15 independent peristaltic valves)
were pressurised with air pressure ranging from 1.5 to 2 bar and were controlled by an internal
lab-made Matlab script. They were connected to the chip and filled with water to completely
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Fig. 4.4 Close-up photography of the PDMS-based microfluidic chemostat inside the microscope
incubator chamber.
remove the air from the control channels, which could have otherwise leaked into the flow
channels. The valves where then tested independently for each channel by an automatic script
closing and opening them at 1 minute interval during 20 minutes to test their robustness and
assess any possible leakage. The flow inlets were then connected to the different components
(TE buffer, one or two inputs DNA, and TX-TL system) and pressurised with 0.1 to 0.4
bar depending on the experiment. I used a home-made cooling system to keep the TX-TL
at 7 °C during the time of the experiment. A watercooling pump was used to cool down
the heated side of a peltier element where the cooled TX-TL system was stored in a tygon
tube. The tube was connected to the chip with a polyetheretherketone tube to minimise the
amount of dead volume not cooled by the peltier element. A Graphical User Interface (GUI)
was developed in Matlab to run the chip characterisation and perform the experiments. The
software enables to program the successive dilutions of the TX-TL-DNA mixture contained
in the reactor at discrete interval of time with a defined number of DNA and TX-TL packages.
Those numbers were computed from the chip characterisation described in the section below.
The loading of DNA and TX-TL system were operated through the use of the first peristaltic
pump (see Fig. 4.5) and after each injection of fresh reactant, the second peristaltic pump
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was used to mix the content of the reactor during 1 min. The duration of the experiment
ranged from a couple of hours to 15 hours.
A B
Fig. 4.5 Schema of a microfluidic peristaltic pump based on Quake valves. A) Mechanism of a single
PDMS Quake valve. On the left, the valve is in its open configuration when it is not pressurised (red).
On the right the valve is in its closed configuration, as pressurisation causes compressing of the flow
channel underneath (blue). B) Actuation sequence of the peristaltic pumps used in the chemostat chip
for mixing and reactants metering.
Characterisation of the microfluidic chemostat
Before each experiment, a calibration procedure was made with the chip to determine the
dilution time td . This term can be found by finding the dilution rate λ which is unique to
each chip. λ may vary because of differences in PDMS ratio, leading to diverse thickness
and stiffness properties between batches of chips. Adjusting the flow rate contributes as
well to the variance of λ between each experiment since the pressure gauge control was
analog-based.
n represents a fixed number of pump cycle delivering a fixed amount of volume nVd at
each interval of time ∆T . For any liquid volume at initial concentration c0, I get
VT c0 −nVDc0 =VT c1,


































Fig. 4.6 Characterisation experiment of a single chemostat reactor to compute the dilution rate, λ .
The number of cycle pumps was fixed at 10 and the successive values of eGFP fluorescence are
plotted in figure B. The blue line represents the exponential fit of the data and the standard deviation
are represented by the dashed black lines. A) Fluorescent image channel (colored) of the reactor at
different dilution time steps (red = high GFP fluorescence, blue = low GFP fluorescence)









with ν = 1−nVTVD being the fraction of the reactor exchanged at each step, I have
cN = c0eNlnν = c0e−λ t ,
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I can now performed the experimental characterisation and compute td from the resulting
data. I used a purified solution of eGFP (3 µM) to initially fill the reactor ring and performed
sequential dilution with Tris buffer. This was repeated for a different range of pump cycles
(n ∈ [3,10]) to get a robust estimation of the parameters. An example of resulting curve is
given in Fig. 4.6. Finally, the following TX-TL experiments can have their dilution rate





Interestingly, the number of pump cycle required to exchange the same percentage
of fraction volume ν was found to be much lower in my design than the original device
reported from Niederholtmeyer et al. [82]. The both designs possess Quake valves of the
same dimensions (100 µM x 100 µM) but my implementation has narrower and shallower
channels, and therefore a greater quantity of fraction volume is displaced when the valves
are pressurised. The proper function of the input peristaltic pump is checked by plotting a
package-responses relationship (see Fig. 4.7 B). The linear correlation between the number of
inserted packages and the average fluorescence cropped from the reactor ring is an important
criteria for inserting the correct fraction of different reactants. The second peristaltic pump
inside the reactor is also checked by plotting the average fluorescence of the reactor through
the mixing time. It should result in a stabilised fluorescence value after some rounds of
mixing, as shown in Fig. 4.7 C, which shows a efficient mixing inside the reactor under 1
minute. Each damped oscillation corresponds to a complete turn of the fluorescent package
getting progressively diluted in the surrounding non fluorescent buffer.
The final step is to proceed to the start of the experiment by setting up the GUI control
software with dilution time computed from the values of ∆T and n previously found. The
detailed procedure steps can be found in section 5.1.4. The typical ∆T was chosen according
to the doubling time of living E. coli at 37 °C, i.e ∼ 20 minutes. It corresponds to a dilution
rate of the reactor of 0.2 h−1. A live-data analysis plugin from ImageJ was used to ensure that
the TX-TL reaction entered a steady state after few hours and to detect any flow abnormalities.
4.1.3 Transcription and Translation at Steady-State
I hypothesised the nanoreactor would enable TX-TL synthesis at constant rate given that the
decreasing rate of TX and TL activities would be compensated by the fresh intake of enzymes
and energy molecules. For the first testing procedure expressing synthetic circuits in TX-TL,
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Fig. 4.7 Characterisation experiments of a single chemostat reactor. A) Bright field of the microfluidic
reactor, the red rectangle area indicates the microscope field of view with the 10x lens for the
fluorescence channel. B) Average fluorescence value of the area over time when active mixing is
operated in the reactor. C) Linear dependency between the number of eGFP packages inserted in the
reactor and the corresponding fluorescence values after 1 minute of active mixing.
I performed protein synthesis from a DNA construct expressing a deGFP reporter driven
by a strong E. coli promoter [39]. deGFP represents a start codon-optimised version of the
enhanced (e)GFP. In order to be compatible with a fast prototyping approach, I used linear
DNA fragments from PCR amplification as template for gene expression [119] (Fig. 4.8
A). Since the complex RecBCD has been shown to degrade linear DNA in TX-TL, purified
GamS was added to the TX-TL system. GamS is a nuclear inhibitor of the RecBCD complex
by interacting with its DNA binding site [26]. The steady state of the TX-TL system, i.e.
when the protein synthesis rate is replenished at the same rate as it is diluted, was reached
after an average of 2 hours with a dilution time of 20 minutes. Increasing the dilution
time to 27 minutes did not have an influence on the time needed to reach the steady state
level (Fig. 4.8 B). The dynamic nature of the dilution time was shown by tuning the time
interval ∆T from 20 to 40 minutes, after the TX-TL reaction reached the initial steady state.
Overshooting of the fluorescence level was observed, corresponding to an increase of deGFP
protein accumulation, which was progressively damped over the dilution steps until reaching
a new steady state several hours later (Fig. 4.8 C).
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Fig. 4.8 TX-TL systems reach a steady state in the chemostat. A) Scheme of a simple linear DNA
template used for the dilution time tuning experiments. The deGFP mRNA is trancribed from a
PCR product downstream of a strong promoter, and is translated into a mature deGFP protein. B)
Steady-state reaction of the corresponding reporter circuit with 7 nM of DNA template, with a dilution
time of 27 minutes. C) Steady-state reaction of the corresponding reporter circuit with 7 nM of DNA
template, with dilution time switching from 20 minutes to 55 minutes.
Monitoring the GFP signal is a robust way to follow the translation process, but it is
important as well, in the context of the RNA-circuitry work presented in this thesis, to monitor
the mRNA production. Therefore, in order to track the transcription production, I tested a
DNA template containing the iSpinach reporter downstream of a T7 bacteriophage promoter
[6]. Like the MGA aptamer, iSpinach is an aptamer which upon binding to its fluorogenic
co-factor 3,5-difluoro-4-hydroxybenzylidene imidazolinone (DFHBI), emits fluorescence
in the GFP spectra (Fig. 4.9 A). Compared to its parent aptamers (Spinach, Spinach 2.0,
Brocoli), iSpinach harbors a greater stability when expressed in in vitro environments such
as TX-TL system. The corresponding experiment in the nano-ractor is presented in Fig.
4.9 B. We observed that the transcription reaches as well a steady-state, in a similar way
that the previously monitored translational GFP activity. The iSpinach reporter is therefore
compatible with the use of the chemostat/microscope set-up, which will be an important
asset for the context of the future experiments based on RNA-based circuits.
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Fig. 4.9 TX system reaches a steady state in the chemostat. A) Scheme of a linear DNA template used
for the experiment. iSpinach is trancribed from a PCR product downstream of a T7 promoter, and
upon folding and binding to its cognate ligand, can be monitored in the GFP channel. B) Steady-state
reaction with 20 nM of the corresponding reporter circuit (dilution time of 45 minutes.
4.1.4 Implementation of Riboswitch Regulators
The next step was to implement genetic circuits, which could be regulated post- or co-
transcriptionally by tuning the concentration of a signal inducer in the nanoreactor. This
would enable the control of the genetic network state by modulating the external inducer
at various concentrations. As a first implementation, the thiamine pyrophosphate (TPP)
riboswitch from B. subtilis tenA gene was cloned into the 5’ UTR of the deGFP reporter
construct. The TPP riboswitch enables the control of gene expression through a variety of
mechanisms in different species [117]. The one used here acts as an OFF-switch in presence
of the TPP molecule. Upon binding with TPP, the stem-loop of the riboswitch sequence
forms a terminator hairpin preventing the host polymerase to extend. In the absence of TPP,
the riboswitch structure forms an anti-terminator structure disrupting the terminator, and
therefore enables the transcription processing. Control experiments were first performed in a
batch-format to determine the activity of the TPP riboswitch in TX-TL systems. Interestingly,
a high concentration of TPP ligand (above 500 µM) was found to reduce significantly the
gene expression level in TX-TL systems (Fig. 4.10 B). To minimise its toxicity level in the
following experiments, the TPP concentration has been set at 100 µM. The TPP riboswitch
functioned as expected in the TX-TL system, with a yield about five-fold higher when
expressed from a circular template compared to the linear PCR product (Fig. 4.10 C). The
GFP expression was reduced by about three-fold in both cases when the TPP-ligand was
present in the system (Fig. 4.10 C). It is interesting to notice that the dynamic range of the
































Fig. 4.10 TPP-riboswitch expression in batch-tube format. A) The two structures of the tenA thiamine
pyrophosphate (TPP, orange circle) riboswitch are shown. Schema adaptated from Sudarsan et al.
[117]. Aptamer domains are highlighted with orange straight or dashed lines. B) Endpoint fluorescence
measurements to determine the toxicity level of TPP on TX-TL systems. C) Normalised endpoint
fluorescence measurements of the Pr-TPP-GFP constructs, either linear or circular in presence or
absence of TPP. Error bars represent the standard deviation over three replicates. Plasmid and linear
DNA concentration were respectively set at 5 nM and 10 nM.
TPP riboswitch is similar with linear or circular template, even tough recent studies suggest
that circular DNA might be a better template to mimic in vivo transcription rates from E. coli
promoters [12].
Modulating the concentration of external inducer in a batch-format reaction can be
cumbersome. The reaction tube consists indeed of a close environment where the tuning of
the concentration parameters is difficult while proceeding to the measurements of TX-TL
activity. The next step was to test if the TPP riboswitch circuit could be expressed in the
nanoreactor. This would enable a direct control of the TPP concentration in the TX-TL
environment, and consequently, of the gene expression. I used 5 nM of Pr-TPP-deGFP
circular template and started the reaction when no TPP was present in the reactor (see Fig.
4.11 B). When the reaction reached a steady-state (after 200 minutes in this experiment),
the input was switched to the same concentration of DNA template mixed with 400 µM
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Fig. 4.11 TX-TL systems express riboswitch circuitry at steady state. A) Schematic of the TPP-
riboswitch circuit. TPP presence promotes the terminator folding and prevents the transcription
elongation. B) and C) Steady-state reactions of the corresponding reporter circuit with 5 nM of
circular DNA template, with a dilution time of 35 minutes. Grey area indicates the concentration of
TPP inside the reactor.
of TPP and loaded in the reactor with an identical number of packages (1 package of
DNA/buffer/TPP for 3 packages of TX-TL). The concentration of TPP increased therefore
with every additional dilution step up to almost 100 µM after 2 hours or 12 dilution steps. As
expected, the deGFP production rate started to decrease a soon as after the second dilution
step of TPP injection (about 20 µM of final concentration in the reactor). As the TPP
concentration was increasing with each dilution step, the deGFP production rate was slowed
down until reaching a stabilised level slightly above the background, corresponding to the
OFF steady-state of the genetic circuit.
In order to test the limits of our microfluidic reactor, the same TPP-riboswitch circuit
expressed in similar conditions was run in a longer experiment (20 hours) (Fig. 4.11 C).
This time, the reaction started in presence of 100 µM of TPP, and the steady-state remained
at a low level of fluorescence. After 300 minutes, the TPP input was switched off and its
concentration in the reactor decreased according to an inverse exponential decay. The deGFP
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production rate increased immediately after the second dilution step, reflecting the results
obtained in Fig. 4.11 B. Once TPP was in negligible working concentration in the reactor ( <
1 µM), the TPP input was switched on again to assess the ability of the reactor to reverse the
state of a genetic circuit multiple times. The deGFP rate decreased successfully, and came
back to the initial OFF steady-state level. For the final step of the operating sequence, the
TPP was switched off once again. We observed a return of deGFP expression, but this time
the level was not as high as the first ON steady-state reached. This likely indicates a problem
with one of the Quake valves, which can become stuck after a long time of operation. The
cooling of our TX-TL system, kept at 7 °C throughout the experiment, may also need to be
enhanced for such long-term measurement. Upgrading the set-up with a better performing
cooling pump or peltier element could enhance the preservation of the TX-TL activities over
time.
4.1.5 Future Use and Development
The nanoreactor was a time-consuming device to implement and characterise but it constitutes
a relevant microfluidic device for the future of the TX-TL experiments presented in this thesis.
The platform has been made accessible for different users by creating a GUI automatising the
dilution operations on the chip and by standardising the numerous input channel connections.
The ensemble of RNA-parts characterised in the 2nd and 3rd chapters will serve as a basis to
build complex logical and dynamical circuits. The nanoreactor will enable the implementation
of genetic circuits with multiple stable states triggered by a signaling molecule, such as the
toggle switch or memory devices. Another promising application will be the engineering
of RNA-based oscillators made of the previously characterised sgRNAs. The combined
SpydCas9/Csy4 CFEs will serve as an ideal expression platform to prototype and test those
multi-components circuits. So far, no oscillators based on RNA-parts have been reported
in the literature, and I believe that a multi-disciplinary approach merging microfluidics, the
RNA cell-free toolbox and computational modeling would be successful.
Furthermore, a new generation of microfluidic chips is currently being tested with eight
independent parallel reactors. This will enable the test of a higher number of conditions
simultaneously on the same chip. This is particularly relevant for complex genetic circuits
made of numerous parts, since the contribution of each DNA part on the circuit performance
could be assessed independently into each reactor with the same environment and set-up
conditions. A prototype chip containing height parallel reactors is shown in Fig. 4.12. The
design is similar as the single reactor chip, with the difference that pressure control lines
were made thinner when crossing over non-targeted channels to not block the flow. The
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Fig. 4.12 Microscope image of the microfluidic chip containing 8 parallel reactors (Overlay of bright
field and fluorescent channels). Most of the reactors are filled with FITC, while the two on the right
have been diluted with several packages of water, demonstrating independent control of each pair of
reactors. Scale bar in white indicates 1 mm.
number of inlets have been increased (from 4 to 6) to increase the possible number of control
parameters.
4.2 Cell-free Expression in Small Volume Compartments
Expressing cell-free reactions at steady-state offers great opportunity for the design of genetic
circuits as deterministic mathematical models of gene expression can be used to predict
and optimise challenging implementations. Furthermore, those bulk cell-free reactions
possess negligible stochastic effects, which is however an important element to consider
when assessing the behavior of circuits expressed in single living cells [100]. A critical step
is to bridge the gap between in vivo implementations of artificial genetic circuits (for example
based on yeast or E. coli cells) and their in vitro counterparts. In this section, I will explore
one novel microfluidic strategy for expressing cell-free systems in confined spaces at the
femtoliter scale.
4.2.1 Femtoliter-Droplet On Demand
Context and Implementation
The work presented here took place in the context of a Compugene collaboration with the
Hardt group (TU Darmstadt, department of Nano- and Mikro-fluidik). The microfluidic work
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Fig. 4.13 A) Schema of the microfluidic set-up. B) Time-lapse images of the on-demand production
of a water in oil droplet. Time in miliseconds. (400 V, pulse duration = 10 ms).
has been realised by Mostafa Shojaeian. This work has led to a publication in ACS analytical
chemistry [107]. Some elements of the papers (i.e. figures) are reproduced here. Mostafa
Shojaeian created a method allowing the generation on-demand of single femtoliter-size
droplets in a reproducible manner. If those droplets can be used as reaction compartments,
it would be an important potential tool in the field of synthetic biology for measuring the
performance of circuit in cell-free in the light of their droplet-to-droplet variability.
The microfluidic platform is described in Fig. 4.13. Simply, the device consists of
a constricted T-junction channel with a parallel and separated U-shaped channel. The U-
channel is filled with water and used as an electrode when connected to the power supply.
The continuous phase (oil) is loaded on the side of the T-channel and the disperse-phase
liquid (such as TX-TL system) is introduced on the other inlet side. The disperse-phase
liquid is then pressurised until partially displacing the continuous phase. A high voltage
sequencer was used to create a voltage pulse of several hundred milliseconds and droplet
formation was observed at the liquid/liquid interface close to the junction. Fabrication used
standard lithography protocol and the methods and material are basically the same as from
the nanoreactor device (see section 4.1.2).
The drop-on demand generator brings along two main advantages for TX-TL systems.
First, it allows the creation of biological reaction compartments with a size comparable to
that of yeast cells and only with one order of magnitude higher than the typical volume of
an E. coli cell, two of the most frequently used cell types in synthetic biology. In other
terms, a comparable number of biologically relevant molecules can be studied in similar
sized compartments. That way, it becomes possible to mimic the stochastic behavior of
biological cells. Second, the droplet generator platform is compatible with the crowding
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Fig. 4.14 TX-TL systems expressed in femtoliter w/o droplets. A) TX-TL expression of 5 nM of
deGFP plasmid inside a batch-format tube. B) Fluorescent channel images of a droplet at different
time points (0, 60, 120 minutes). Scale bar represents 2.5 µM. C) Averaged fluorescence time-course
kinetics of n = 23 droplets containing 5 nM of deGFP template. Droplets without DNA template is
represented by the grey line (n = 3). Errors bars are the standard deviations from the mean.
characteristic required for biological cells. The interior of living cells is densely packed with
different molecular species, translated into a functional highly viscous environment. The
platform presented here has demonstrated the compatibility with generating droplets having
a viscosity more than 104-fold higher than that of water [107]. This will be highly useful for
the characterisation of RNA-based circuits where little has been done yet to understand the
localisation and bursting effect of mRNA on circuit prototyping [87].
Femtoliter-size droplets as biological compartments
In order to test if this platform is compatible with synthetic biology applications, I performed
two of the most fundamental biochemical reactions inside the droplets: gene transcription
and mRNA-translation. The CFE and reporter plasmid used were the same as in section 4.1.3
for the chemostat characterisation. The gene is first transcribed into mRNA and subsequently
translated into protein. The synthesis of deGFP was analysed in a time-dependent manner,
and the product of the reaction when performed at standard (“bulk”)-conditions in a batch-
format volume (10 µL) is quantified in Fig. 4.14. deGFP-fluorescence starts at roughly 30
min and follows a linear increase for 1 hour before to reach a plateau roughly at 3 h.
The TX-TL reaction mix was enclosed in the w/o droplets after 60 min of “bulk” reaction
(arrow in Fig. 4.14 A). Droplets with diameters between 3 and 8 µM were tested, corre-
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Fig. 4.15 In vitro transcription of the iSpinach aptamer inside femtoliter w/o droplets. A) Fluorescent
channel images of one droplet at different time points. Scale bar represents 3 µM. B) Averaged
fluorescence time-course kinetics of 9 droplets containing 20 nM of T7-iSpinach linear template
(Black curve). Droplets without DNA template is represented by the grey line (n = 3). Errors bars are
the standard deviations from the mean.
sponding to droplet volumes between 20 fL and 300 fL. Cropped images of the fluorescent
channel show a 5.1 µm diameter droplet at three different time-points (Fig. 4.14 B). The
time-course fluorescence signal of deGFP averaged over 23 droplets is shown in Fig. 4.14 C).
While the droplets containing no DNA template do not show any detectable signal over the
observed time frame, the fluorescence signal in the droplets increases over 2 h. An initial
fast increase within the first 15 min is followed by a second slower increase thereafter. As
expected and in accordance with the literature, the data show a high statistical variance,
likely due to the stochastic distribution of the TX-TL-extract components, e.g. number of
polymerases and ribosomes, in the small reaction volumes. In that sense, the droplets seem
to mimic the stochastic behavior of gene expression in single cells. This platform would
be therefore suitable for the studying of the extrinsic and intrinsic noise distribution among
droplet populations.
As an additional experiment to expand the platform possibilities, I tested if low-molecular
mass ligands can diffuse across the oil/water interface of the droplets in order to bind to a
cognate receptor molecule and triggers a biochemical switch.
For this, in vitro transcription reaction was set up within the droplets to synthesise the
“light-up” RNA aptamer iSpinach (see section 4.1.3 for more details). The fluorophore was
solubilised in the oil phase and thereafter injected into the microfluidic device. About 2–3
minutes after droplet formation, the droplets started to fluoresce, reaching a plateau after
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only 30 min. Those data are compatible with the previously published data recording both
the deGFP and mRNA level in TX-TL systems (see chapter 3), where usually the maximum
mRNA production rate is reached earlier than the maximum protein production rate. Cropped
images of the fluorescent channel of a 5.9 µm diameter droplet at different time points are
shown in Fig. 4.2.1 A. Fig. B displays the averaged time-course fluorescence intensity from a
sample of nine droplets. As before, the strong electric field required for droplet formation did
not adversely disrupt the bioactive structure of the biomolecules, in that case the polyanionic
RNA molecules. Similar to the case of the TX-TL system, this reinforces the compatibility
of the droplets produced using the method described above with biomolecular reactions.
Demonstrating the proper folding ability of mRNA in those droplets is important for testing
synthetic circuits regulated by RNA-based devices whose functionality relies on the folding




Characterisation of several logic AND-gates built on multi-level RNA activators was per-
formed. To the best of my knowledge, this is the first study which combined the STAR and
toehold regulators, two highly efficient RNA activators. TX-TL system was used together
with a robotic liquid handler (I-Dot), which enabled to perform precise, fast and down-scaled
parallel reactions for testing a large range of concentrations. From the resulting dose-response
matrices, the saturation concentrations which maximise the dynamic range of the AND-gates
were determined. A similar qualitative behaviour was observed for the gates as for the single
parts; the transcriptional activator STAR needed threefold the amount of the translational
activator trigger to reach saturation. This agreement between single parts and gates shows
the potential of the STAR-toehold system for synthetic circuit design where modularity of
parts is desirable. Establishing the I-Dot framework for TX-TL system was also the first step
towards a pipeline automation for circuit-prototyping with the Compugene robotic platform.
The next critical step will be to merge this framework with sequential optimal experimental
design for testing and prototyping RNA-based circuitry. An iterative feed-forward loop could
be implemented between the I-Dot and the fluorescence plate reader. This would enable
the automatic screening for optimal concentrations of DNA parts or inducers in TX-TL
systems. As an example, it would be possible to automatically determine the concentrations
maximising the highest dynamic range for several different AND-gates, and combine them
thereafter based on those concentrations.
Experimentally, a remarkable AND-gate based on the STAR 6 and toehold 3 parts was
identified. Its production rate was as high as for the unregulated sfGFP, showing a great
potential for metabolic engineering. I suspect that local co-folding of the RNA regulators
hinders the translational process of the remaining gates. This hypothesis is supported by the
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dramatic enhancement of the AND-gate with the Csy4 processing hairpin between the STAR 6
and toehold 2 components. In future work, it may be worthwhile to perform more advanced
secondary structure analysis and combine it with the ODE population model to obtain better
quantitative insights. However, Angenent-Mari et al. [4] have highlighted the weakness of
state-of-the-art thermodynamics parameters and kinetic models for predicting the efficiency
of toehold switches. Instead, they found that deep neural networks outperformed those
features in engineering and understanding of RNA-based switches. It would be interesting to
apply this novel computational methodology to the RNA-based gates in order to confirm this
trend. Moreover, Yim et al. [135] have demonstrated the use of next-generation sequencing
in TX-TL systems, which could be a solution for the generation of a high volume of data,
required for neural networks analysis.
Finally, TX-TL based diagnostic platforms with toehold switches have been recently
used for the rapid and low-cost detection of specific RNA genome sequences [90, 91]. As the
STAR activators can be computationally designed [16], coupling the toehold sensors with
a STAR module could increase the flexibility and sensitivity of the current bio-molecular
diagnostic tools. Since the current ones are mainly based on the toehold switches, the users
have typically a waiting time over a couple of hours (due to the translation and protein
maturation times), which could be scaled down to the order of minute with a STAR-based
sensor. The transcription process could be read out with an aptamer, like the tandem of
MGAs used in this thesis. Recently, Alam et al. [3] have applied this approach to a real world
problem by designing a cell-free biosensing platform that uses Spinach aptamers activated
by ligand induction to detect harmful contaminants in aqueous samples.
Finally, extending the catalogue of RNA-based components to the TX-TL toolbox will
enable the engineering of additional Boolean functions. In particular, the sgRNA repressors
allow the construction of NAND gates, which are universal gates. In other terms, any other
gate can be represented as a combination of NAND gates, which has important implications
for the creation of advanced RNA-based circuits. A current limitation to this paradigm is,
however, the limited number of orthogonal STAR components available. As the current
library is mainly based on the same terminator hairpin, only a few STARs can be effectively
combined without crosstalks. In theory, there is nothing preventing the engineering of novel
STAR devices based on a set of artificial terminators [17], as this would enable a greater
library diversity.
All gates were successfully transferred from in vitro to in vivo, demonstrating the versa-
tility of TX-TL systems for the fast prototyping of RNA-based circuits. Additional studies to
transfer the dose-response matrices from the TX-TL systems to an in vivo counterpart (for
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instance with inducible promoters) may help engineer more balanced and efficient circuits in
living cells. As both dSpyCas9 and Csy4 systems have been first established in vivo, there
is no obvious limitations to their transfer in living cells. The cloning of advanced circuits
composed of numerous sRNAs can, however, become increasingly challenging. The mi-
crofluidic chemostat will be a valuable instrument to measure, test, and rewire these complex
circuits in an accessible way. It will be particularly useful for the dynamic characterisation






6.1.1 Cell-free Extract Preparation
Lysate preparation
The 3rd chapter of this thesis investigates parameter variations related to the CFE protocol.
In this subsection, only the most efficient protocol for the production of cell-free system is
presented.
E. coli BL21 Rosetta 2 were streaked overnight on agar plate containing chloramphenicol
(and ampicilin, for the production of functionalised extracts). One colony was picked and
inoculated overnight in 50 mL 2xYT supplemented with antibiotic(s) for growth at 37°C.
After a minimum of 15 hours, 10 to 20 mL of the stationary culture was used to inoculate 200
mL to 1 L of 2xYT + P media (16 g/L tryptone, 10 g/L yeast extract, 5 g/L sodium chloride,
7 g/L potassium phosphate dibasic, 3 g/L potassium phosphate monobasic) in a 1 L to 5 L
baffled flask. For most of the experiments not related to the study of optical density (OD600),
cells were grown at 37 °C and 200 rpm to 3.5 ± 0.1 OD600. Centrifuge bottles were filled up
to 300 mL and centrifuged for 10 minutes at 4000 g at 4 °C and supernatants was discarded.
The pellets were next washed three times with 25 mL buffer S30A (50 mM Tris-base, 14
mM magnesium glutamate, 60 mM potassium glutamate, 2 mM DTT, brought to pH 7.7 with
acetic acid). Each step of washing was separated with a centrifugication step at 4000 g at
4 °C for 10 minutes. A fourth centrifuging step at 3000 g at 4°C for 10 minutes enabled to
remove the remaining traces of buffer.
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The pellets were then resuspended in 1 mL of Buffer S30A per gram of dry pellet. 700 µL of
the suspension was splitted in the necessary number of 2 mL eppendorf tubes. The pellet
suspensions were then lysed with a sonicator (QSonica Q125 with a 3.175 mm diameter
probe, 50% amplitude, 20 kHz, and 10 secondes ON/OFF pulses). Each sample was sonicated
until reaching 500 J. For CFEs corresponding to the experiments detailed in the 3rd chapter,
1 mM of DTT was added to each crude lysate immediately after sonication. The cell lysate
was then centrifuged for 10 minutes at 4 °C and 12000 g. The supernatant was removed
and placed into an incubator set up at 37 °C and 200 rpm for 80 minutes. After this run-off
reaction, the supernatant was taken and centrifuged again for 10 minutes at 4 °C and 12000
g. For cell-free extract preparation including a dialysis step, the extract was dialysed into a
10K MWCO Slide-a-Lyzer dyalisis cassette put in a 1 L buffer S30B (14 mM magnesium
glutamate, 60 mM potassium glutamate, 1 mM DTT, bought to pH 8.2 with 2 M Tris-base)
refrigerated at 4°C. A final centrifugation step for 10 minutes at 4 °C and 12000 g was
performed and the supernatant was aliquoted as 40 µL samples into PCR tubes. The aliquots
were snap-frozen into liquid nitrogen and stocked at -80 °C.
Energy buffer preparation
Energy buffer for the cell-free system was prepared according to table 6.8. The master-mix
was aliquoted as 45 µL samples into PCR tubes. The aliquots were snap-frozen into liquid
nitrogen and stocked at -80 °C. The ratio between cell-extract and energy buffer were kept to
33:42. The standard concentration of magnesium glutamate and potassium glutamate were
kept respectively at 10 nM and 140 nM. Each newly produced cell-extract was titrated with
magnesium glutamate in the range of 10-20 nM. Some experiments involved the titration of
potassium glutamate between 80 nM and 200 nM.
Cell-free experiment
The final cell-free mixture is composed of: 10-20 mM magnesium glutamate; 130 mM
potassium glutamate; 1.5 mM ATP; 1.1 mM each of GTP, UTP, and CTP; 0.034 mg/mL
folinic acid; 0.171 mg/mL tRNA; 2 mM amino acids; 30 mM 3-PGA; 0.33 mM NAD; 0.27
mM CoA; 1.5 mM DTT; 1.5 mM spermidine; 57 mM HEPES, 0.75 mM cAMP, 34% CFE per
volume, plasmid DNA and Milli-Q water. Each experiment was prepared in a final volume
of 20 µl and 3 replicates of 5 µl were dispensed into a low volume 384 well microplate. For
experiments involving MGA RNA read-out, the plates were chilled beforehand into the -20 °C
freezer to slow the start of the kinetic reactions. Once all reactions were pipetted, a transparent
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seal was applied to prevent evaporation of the reactions. Finally, the microplate was vortexed
and centrifuged again before being ready for either kinetic or endpoint measurements. The
plate was read with a ClarioSTAR plus or PHERAstar FSX set-up at 29 °C for 10 hours. For
endpoint measurements, the plate was let overnight (16 hours) in the incubator at 29 °C. The
GFP signal was measured every 2 minutes with the direct optic bottom module FI 485/520
(Ex/Em), adjusting gain to 120 with 20 flashes per well and z-height optimised according to
each experiment. For recording multiple fluorescence channels, the ClarioSTAR plus was
used with the following (Ex/Em) optic parameters: GFP (485/520), RFP (530/585), MGA
(610/660).
Calibration curves for cell-free reactions
To quantify the production of mRNA and protein in TX-TL, calibration curves were ob-
tained by titrating purified mRNA and proteins at various concentrations with the same
plate reader parameter conditions. sfGFP calibration was obtained by titrating eGFP, and
mRFP1/dtTomato from purified dtTomato (Takarabio). For the mRNA quantification, pu-
rified sfGFP-MGA4x mRNA was used, obtained from a T7 in vitro transcription. The
mRNA was heated at 80 °C for 5 minutes and then cooled down at RT for 15 minutes before
measurement.
6.1.2 Purification of Biological Molecules
RNA purification
For experiments involving pre-expressed mRNAs, the RNAs were transcribed from PCR-
amplified templates, all containing three 5-terminal guanosyl residues to facilitate transcrip-
tion in vitro using T7 RNA polymerase. For this, two oligonucleotides were designed with an
overlap of 35 bp containing the T7 promoter sequence and amplified using Q5 High-Fidelity
DNA polymerase (NEB) according to the supplier’s instructions. After ethanol precipitation,
the DNA template was used for in vitro transcription with T7 RNA polymerase (NEB) as
reported by the manufacturer. The RNA was gel-purified and molarity was determined
by spectrophotometric measurements using NanoDrop 1000 Spectrophotometer (Thermo
Scientific).





















Fig. 6.1 Calibration curves for TX-TL experiments. A) Calibration curve for dtTomato. B) Calibration
curve for sfGFP. C) Calibration curve for sfGFP-MGA4x mRNA.
In vitro transcription with T7 polymerase
The DNA template used for in vitro transcription was first purified with sodium acetate/ethanol
precipitation. HiScribe T7 Quick High Yield RNA Synthesis Kit (NEB) was used to generate
the RNA required for the MGA degradation assays and for the pre-expressed RNA activators
experiments. The reaction containing the elements listed in table 6.1 were assembled at room
temperature. The mix was then incubated for at least 2 hours at 37 °C. The sample was finally
treated with DNaseI and purified with a RNA-clean and concentrator kit (ZymoResearch).
Protein purification
GamS: E. coli strain BL21 DE3 was transformed with a plasmid encoding for GamS with a
polyhistidine tag under the control of an inducible promoter (see Table 6.17). One single
6.1 Methods 91
Table 6.1 T7 transcription assembly mix.
Nuclease free water x µl
NTPs buffer mix 10 µl (10 mM each NTP final)
DNA template x µl (500 ng to 2 µg)
T7 RNA Polymerase 2 µl
Total reaction volume 20 µl
Table 6.2 Buffer composition for GamS purification.
Buffer Composition Final concentration
GamS
Lysis

















colony was picked up and grown as a starter culture in 4ml of LB Medium with the addition
of 4 µl (100 mg/ml) ampicillin over night. 1ml of the starter culture was transferred into a
flask with 30 ml of LB Medium and grown to an OD600 of 0.5 at 37 °C. The culture was
induced with 0.025 % [w/v] of arabinose and incubated at 30 °C for 3 h 30 min. The grown
cultures were split equally into 50 ml falcon tubes and centrifuged at 4000 g for 20 min at
4 °C. The resulting supernatant was discarded and the pellets were flash-frozen in liquid
nitrogen and stored at -80 °C. The pellets were weighed and 10x the weight of the pellet was
added in lysis buffer (see Table 6.2). The suspended cells were sonicated at 20 % power for 1
minute, four times every 5 minutes. The lysate was cleared by centrifugation at 4000 g and 4
°C for 20 minutes. Ni-NTA agarose (Qiagen) was added into a 15 ml Falcon tube centrifuged
at 4000 g for one minute and the supernatant was discarded. 15 ml of the cleared lysate were
added to the Ni-NTA slurry agarose and incubated after vortexing. The mix was applied to a
drip column and washed twice with 15 column volumes of native wash buffer. The protein
was eluted in 2 column volumes of elution buffer in 2 ml fractions. A SDS-PAGE was used
to analyse the cleared lysate, the wash fractions and the elution fractions.
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Table 6.3 Buffer composition for SDS-PAGE electrophoresis.
Buffer Composition Final concentration
TAE 50x
EDTA disodium salt 50 mM
Tris base 2 M
Glacial / acetic acid 1 M
Laemmli
buffer 2x
Tris-HCl pH 6.8 100 mM
SDS 2%
Glycerol 20%
β -mercaptoethanol 25 mM
SDS-PAGE for protein electrophoresis
Samples were incubated at 95 °C for 5 minutes in 2x Laemmli buffer (sample and buffer 1:1,
see Table 6.3). Samples were loaded onto the BioRadTM© mini-protean precast gel. The
electrophoresis was run at 140 V for one hour.
6.1.3 Methods for Molecular Cloning
Plasmid assembly
The construction of the plasmid library is based on plasmids previously published: pJBL2801
was a gift from Julius Lucks (Addgene plasmid 71207) and was used for cloning the STARs,
triggers, sgRNAs and UTRs variants; pJBL2807 was a gift from Julius Lucks (Addgene
plasmid 71203) and was used for cloning the sense, toehold and the nine combined gates.
Golden gate and Gibson assembly were used for cloning the inserts with length longer than
100 bps. Inserts were obtained by PCR, and backbones either by PCR or restriction enzymes.
Q5 site directed mutagenesis kit from NEB was used for cloning the inserts inferiors at
100 bps. Some of the constructs, such as the sRNA operon, were synthesised from Genscript,
and inserted into pUC57-mini vector. Oligos used for the various assemblies or mutagenesis
were ordered from Sigma Aldrich. Sanger sequencing verified all constructed plasmids.
The plasmids or linear fragments used in the 4th chapter are based in plasmids used and
published by Shin and Noireaux [106], in particular pBEST-p70a-deGFP-t500. pBEST-p70a-
UTR-deGFP-6xHis-T500 was a gift from Lital Alfonta (Addgene plasmid 92224).
Plasmids were prepared using a NucleoBond Extra Midi Plus (Macherey-Nagel) and fol-
lowed by isopropanol precipitation and eluted with 10 mM Tris-HCl, pH=8.5, and quantified
using a NanoDrop 1000. Those having an insufficient purity were subject to a Phenol-
6.1 Methods 93
Table 6.4 PCR mixture.
Reagent Final concentration
Forward Primer 2 µM
Reverse Primer 2 µM
dNTPs 200 µM
DNA template 5 to 10 ng
Q5/phusion Polymerase 1 U
Q5/phusion Buffer 5x 1 x
Nuclease free water to 50 µl
Table 6.5 Thermocyclar program for Q5/phusion PCR. Steps highlighted in cyan are cycled for 30 to
35 times.
Step Duration(s) Temperature (°C)
Initial denaturation 120 98
Denaturation 15 98
Annealing 15 to 30 50-70
Elongation 30 s/kb 72
Final elongation 180 72
Cool-down ∞ 4
chloroform extraction followed by a novel step of isopropanol precipitation. The purity
quality of the plasmid was critical to achieve reproducible results in the CFEs.
Plamid names, resistances, and part composition are listed in Table 6.17.
PCR of DNA fragments
Two different high-fidelity polymerases, Q5 and Phusion (NEB) were used to amplify insert
or templates sequences with two overlapping primers from a vector to create a double
stranded DNA that can be used for cloning. For colony PCR, Taq polymerase (NEB) was
used. Temperature for primer hybridization and extension elongation times were adjusted to
target length and primer-vector hybridization. temperatures. Mixture details and protocol are
given in table 6.4 and 6.5.
Preparation of E.coli competent cells
All transformations with E.coli strain DH5α are performed following the protocol of zymo
research Mix Go kit. Cells were grown to mid-log phase (OD600 = 0.4 - 0.6) and placed
94 Material and Methods
on ice for 10 min . The cells were harvested by centrifugation at 2500 g for 10 min at 4
°C. Supernatant was removed and cells were washed twice with 5 ml ice-cold wash buffer.
The final step is the resuspension of the pellet in 5 ml cold competent buffer. The cells are
aliquoted and stored in a -80 °C refrigerator. The transformation includes thawing on ice,
addition of 1-5 µL circular DNA, an hour of incubation at 37 °C under constant shacking and
last the spreading onto pre-heated agar plates with the corresponding resistant marker. In this
thesis, Ampicillin, Chloramphenicol and Kanamycin were used as selective pressure.
Flow cytometry analysis
The plasmid containing the regulatory element with the reporter and the plasmid contain-
ing the activating RNA were transferred into E. coli TOP10 cells by the calcium chloride
method. The cells were grown on LB agar plates containing the antibiotics ampicillin and
chloramphenicol over night at 37 ◦C. A single colony was used to inoculate 4 ml of LB
containing the needed antibiotics for selection. The cells were grown over night (37 ◦C,
150 rpm). For sfGFP analysis the cells were diluted 1:10 with PBS into a 96-well plate
(flat bottom, Greiner). Fluorescence was analysed by using the CytoFlex S cytometer from
Beckmann. For sfGFP excitation a 488 nm laser was used and emission was detected by
a 510/20 nm filter. For each sample 25 000 events were measured. Each experiment was
repeated three times.
Nucleic acid quantification
To measure the DNA or RNA concentration, a Nanodrop ND-1000 was used by loading 1.5
µM of nucleic acid on the pedestal. The absorbance was read at 260 nM and the concentration
was determined using the Beer-Lambert’s law.
Gel electrophoresis
For DNA extraction and analysis, agarose gel was used. After casting the gels with agarose
concentrations ranging from 1% to 3%, samples were mixed with DNA loading dye (5:1)
and run alongside a DNA ladder of adequate size. Gels were run in 1x TAE buffer containing
1 µM of SYBR safe stain, at 6 V/cm for 20-60 min. DNA bands were visualised with 254
nm light for analytical purposes or extracted with 360 nm light.
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Fluorescence Activated Cell Sorting for selection of the S6T3-sfGFP mutants
E. coli Top10 were co-transformed with the mutated library of S6T3-Nx10-sfGFP and with
the corresponding activators plasmid (STAR 6 and trigger 3). Several plates were streaked
together and grow in 50 mL culture of LB overnight. 1 mL is taken out, centrifuged 5 min at
3000 rpm at 4 °C. Cells are washed with 1 mL 1x PBS and centrifuged again in the same
conditions. Cells are then diluted (1:10) and resuspended in 1 mL PBS and filtrated through
a 40 µM cell strainer. After sorting, cells were plated to with 100 colonies per plate. Flowjo
was used for gating the data and plotting the fluorescence level per cell count.
6.1.4 Microfluidic Chips
Master mold fabrication
All layouts were designed with AutoCAD (AutoDesk). Corresponding foil plots were ordered
for each layer of the final design. For structures below 30 µM resolution, chrome masks were
ordered. The steps of the fabrication and exposure of multiple layers are described in Table
6.7. At the end of the exposure, the wafer is coated with a highly hydrophobic chemical.
The wafer is placed inside a vacuum chamber, together with 100 µL of 1H,1H,2H,2H-
Perfluorodecyltrichlorosilane sealed and vacuum is applied. Through evaporation, a thin
layer is applied to the silane oxid wafer. This coating increases the robustness of the wafer
and can therefore be re-used for casting PDMS chips multiple times. The hydrophobic
coating is repeated every 20 batches of chips fabrication.
PDMS chips replica
A two compound polymer, polydimethylsiloxane (PDMS) is mixed in weighting trays and
placed into a desiccating chamber for degassing. For the control layer, 40 g liquid PDMS
and 4 g of the cross-linking agent are mixed. The flow layer has a ratio of 20:1. After 2 h
of degassing, the mixed PDMS is poured on the master mold, either in a petri-dish for the
control layer or directly done in the spin coater for the flow layer. The thickness of the flow
layer is adjusted by rotation speed and duration. The typical program used for the flow layer
is described in Table 6.6.
Both wafers were degassed again for 1 h. A preheated oven was then used to cure the
molded wafers at 75 °C.The flow layer was taken out after 15 min to have partially cured
PDMS, offering better bonding property for the later baking step. The control layer was
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Table 6.6 Spin-coater program for the flow layer. The acceleration step high-lighted in cyan is the
critical step where the thickness of the PDMS layer can be adjusted between 5 and 20 µm.




removed from the oven after 30 min and cooled down at room temperature. Next, the
cured PDMS of the control layer were cut into rectangular chip size with the help of the
border marks. The control layer chips were then aligned onto the flow layer according to
the alignment marks (a big and a small cross that fall together). The process of alignment is
critical for the proper working of the final microfluidic chips and requires to be undertaken
under a stereo microscope. The layers’ assembly was baked overnight in the oven at 75 °C
in order to seal the bond between them. Finally, the chips were peeled off the flow wafer
and a 0.5 mm punch marker were used to make the holes for every flow and control channel
connection. The resulting PDMS chips were bonded to cover slips by activating the surfaces
with a plasma oven treatment of 10 secs.
6.1.5 Mathematical Modeling
This section describes the Bayesian inference framework developed by Maleen Hanst for the
modelling of the RNA-based gates described in the 2nd chapter.
Parallel tempering:
In Bayesian parameter inference, we are concerned with finding the posterior distribution of
the parameters θ included in our model, given the experimental data Y ;
p(θ |Y ) ∝ p(Y |θ) p(θ).
To identify this distribution, MCMC parallel tempering [30] was used. This method improves
the exploration of the whole parameter space with faster convergence. In the following, the
main formulas of the algorithm used in this work are stated.
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Table 6.7 Soft-lithography protocols for the silicon wafers.
Layer 1 : Herringbone / Array structures
Step 10 µm with SU8-2005
1. Wash wafer with acetone, then isopropanol
2. Coating with TI Prime "Haftvermittler"
3. Spin-coating : 500 rpm 10 s at 500 rpm; 30 s at 1500 rpm
4. Softbake: 5 min at 50 ◦C
5. Exposure: 120 mJ/cm2 at 365 nm, hard contact mode
6. Resting for 10 min
7. Post exposure bake (PEB) 3 min to 50 ◦C, 3 min to 65 ◦C, 3 min to 95 ◦C
8. Developing for 40 s
9. Rinse with isopropanol, then water
10. Hard bake: 5 min at 130 ◦C
Layer 2 : Flow/control channels
Step 20 µm with SU8-25
1. Wash wafer with acetone, then isopropanol
2. Coating with TI Prime "Haftvermittler"
3. Spin-coating : 500 rpm 10 s at 500 rpm; 30 s at 4000 rpm
4. Softbake: 5 min at 50 ◦C, 5 min to 65 ◦C, 5 min to 95 ◦C
5. Exposure: 300 mJ/cm2 at 365 nm, hard contact mode
6. Resting for 10 min
7. PEB 6 min at 95 ◦C
8. Developing for 3:30 min
9. Rinse with isopropanol, then water
10. Hard bake: 2 min at 130 ◦C and slow cool down
Layer 3 : Round channels
Step 10 µm with AZ4562
1. Wash wafer with acetone, then isopropanol
2. Coating with TI Prime "Haftvermittler"
3. Spin-coating : 500 rpm 10 s at 500 rpm; 30 s at 1700 rpm
4. Softbake: 10 min at 100 ◦C
5. Exposure: 700 mJ/cm2 at 405 nm, hard contact mode
6. Resting for 5 min
7. Developing for 3:30 min
8. Rinse with isopropanol, then water
9. Hard bake: 2 min at 130 ◦C and slow cool down
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Our log-likelihood is determined by the common assumption of independent normally
distributed measurement deviations and we denote it similar to Moore et al. [79] by














where C contains the experimental conditions (in our case the different input concentrations
of the activator plasmids), and T contains the different time points of the measurements
(in our case, measurements were taken every two minutes). The second sum stands for the
three replicates measured for each concentration. The simulated model data of the reporter
fluorescence intensity are indicated by Xc,t(θ) due to their dependence on the activator input
concentration, the evaluation time, and the parameter θ . The experimental data as well
are indicated by the activator concentration, the time point of the measurement and the
enumeration of the replicate. From the three replicates for each concentration and each time
point, the empirical standard deviation σc,t was computed. Further, an additional “base noise”
σb was set to capture the experimental irregularities up to 25 minutes.
As a prior distribution, we choose the uniform distribution on the interval of ± five orders
of magnitude around parameter literature values (e.g. taken from Hu et al. [49]).
Samples are drawn from the tempered posteriors, i.e. from the posterior distributions of
different temperatures given as follows
pi(θ |Y ) ∝ p(Y |θ)βiπ(θ),
where βi is the ith inverse temperature (thermodynamic parameter). The inverse temperatures
were chosen according to the following – geometric – temperature schedule: Denoting the
predefined number of different temperatures by Nt , e.g. 50, one further chooses a minimal
inverse temperature, here 10−6, and identifies q ∈ (0,1) such that qNt−1 = 10−6. Therewith,
the set of inverse temperatures is given by
{βi := qi−1 | i = 1, . . .Nt},
where β1 = 1 corresponds to the “original temperature”, e.g. to the true posterior distribution.
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The acceptance probability for the ith chain to switch to a proposed sample θ ′ is deter-
mined by the Metropolis criterion and given by
a(θ ′ |θ) = min
(
1,




The proposal distribution for a new parameter set is given by the normal distribution
with mean equal to the current parameter values and predefined proper variances that are
scaled with some predefined constant greater than 1 which scales exponentially with the
enumeration of the temperatures, i.e., the highest temperature possesses the largest variance.
Finally, in each sampling step, there is a predefined number of possible swaps of current
samples belonging to the differently tempered chains: picking randomly one of the chains,
its corresponding current sample can possibly be changed with the current sample from the
chain with next higher temperature according to the following swap acceptance probability
[50, 118]








Having characterised the parameter posterior distribution, the computation of the posterior
predictive distribution is given for a new data point y′ at time t ′ regarding to an input
concentration c′ via
p(y′ |Y ) =
∫





p(x |θ) p(θ |Y )dθ
)
dx,
where in the case of a deterministic model, we have p(x |θ) = δ (x−Xc′,t ′(θ)).
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Table 6.8 List of chemicals and reagents for cell-extract preparation.
Chemicals/Reagents for cell-extract Manufacturer
2x YT media Sigma Aldrich, USA
3-PGA Sigma Aldrich, USA
HEPES Carl Roth, Karlsruhe
tRNA Roche Applied Sciences, Penzberg
CoA Sigma Aldrich, USA
cAMP Sigma Aldrich, USA
Folinic Acid Sigma Aldrich, USA
Magnesium L-glutamate (C10H16MgN2O8) Sigma Aldrich, USA
NAD Carl Roth, Karlsruhe
Potassium L-glutamate (C5H8KNO4) Sigma Aldrich, USA
PEG-8000 Carl Roth, Karlsruhe
RTS Amino Acid Sampler Biotech Rabbit, USA
Spermidine Roth, Karlsruhe
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Table 6.9 List of chemicals and reagents.
Chemicals/Reagents for molecular biology Manufacturer
Agar Carl Roth, Karlsruhe
Agarose Carl Roth, Karlsruhe
Ampicilin Carl Roth, Karlsruhe
Calcium chloride Carl Roth, Karlsruhe
Deoxynucleoside triphosphate (dNTPs) Thermofischer Scientific, USA
Dimethyl sulfoxide Carl Roth, Karlsruhe
Dulbecco’s Phosphate buffered Saline (PBS) Life Technologies, USA
Dithiothreitole (DTT) Roth, Karlsruhe
Ethanol, denatured VWR, Darmstadt
Ethanol, absolute VWR, Darmstadt
FlowClean Cleaning Agent Beckman Coulter
Glycerol Carl Roth, Karlsruhe
Hydrochloric acid (HCl) Carl Roth, Karlsruhe
Isopropanol, p.a. VWR, Darmstadt
Kanamycin Carl Roth, Karlsruhe
Acrylamide (Rotiphorese Gel 40, 19:1) Sigma Aldrich, USA
Potassium chloride (KCl) Carl Roth, Karlsruhe
Sodium chloride (NaCl) Carl Roth, Karlsruhe
Sodium dodecyl sulfate (SDS), pellets Roth, Karlsruhe
SYBR Green Thermofischer Scientific, USA
TEMED Roth, Karlsruhe
Tris Carl Roth, Karlsruhe
Tryptone Carl Roth, Karlsruhe
Urea Carl Roth, Karlsruhe
Yeast extract Carl Roth, Karlsruhe
Chemicals/Reagents for microfluidics Manufacturer
PDMS Corning, USA
SU8 2005 Micro Resist Technologies, Berlin
SU8 developer Micro Resist Technologies, Berlin
SU8 2025 Micro Resist Technologies, Berlin
AZ4562 Micro Resist Technologies, Berlin
Methyltrichlorosilane Sigma Aldrich, USA
SU8 2025 Corning, USA
Cover glas 50 x 24 mm Carl Roth, Karlsruhe
Metal plugs 23G Darwin Microfluidics, Paris
Tygon Tubing 0.51 mm ID Darwin Microfluidics, Paris
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Table 6.10 List of utilised softwares.
Software Purpose
Matlab 2018a Data analysis, model generation
ImageJ 1.52n Image analysis, data visualization
NIS-Elements 4,00 Microscope control and imaging software
OmmniGraffle 6.6.2 Creation of graphics
Nupack 3.2 RNA secondary structure computation
Python 3.1 Scripting routines
FlowJo v10 Flow cytometry data analysis
AutoCAD 2015 Microfluidic design
Table 6.11 List of utilised instruments.
Instrument Manufacturer
Centrifuges CellStar,
CytoFlex S Beckman-Coulter, Krefeld
Heating block 30
Incubator (1) Heidolph, Schwabach
Incubator (2) Heraeus Christ, Osterode
Infinite© M200 plate reader Tecan Trading AG, Switzerland
CLARIOstar plus BMG Labtech, Offenburg
PHERAstar BMG, Labtech, Offenburg
Milli-Q water purification system EMD Millipore, France
NanoDrop© ND-1000 Peqlab, Erlangen
SimplyAmp© PCR LifeTechnologies, Carlsbad
Inverted microscope Eclipse Ti Nikon, Tokyo
Gel iX20 Imager INTAS, Göttingen
Plasma oven Diener electronics, Ebhausen
Spin Coater Laurell Technologies, Hong Kong
Solenoid Valves The Lee Company, Westbrook
I-Dot One (Nanoliter dispenser) Dispendix
Cell sorter sh800 Sony, Tokyo
Balance Acculab, USA
Table 6.12 List of utilised kits.
Kit Manufacturer
QIAprep© Spin Miniprep Kit QIAGEN, Hilden
NucleoBond© Xtra Spin Midiprep Kit Macherey-Nagel, Düren
NucleoSpin© Gel-PCR Clean-up© Xtra Spin Midiprep Kit Macherey-Nagel, Düren
RNA Clean Concentrator-25 Kit Zymo Research, USA
6.2 Materials 103
6.2 Material
6.2.1 List of Chemicals Used
Table 6.13 List of utilised enzymes and ladders.
Enzymes and purified proteins Manufacturer
RNase inhibitor MOLOX, Hilden
Q5 DNA-polymerase New England Biolabs, USA
Phusion DNA-polymerase New England Biolabs, USA
Kld enzyme mix New England Biolabs, USA
T4 DNA ligase New England Biolabs, USA
SpydCas9 Abm Good, USA
Taq DNA-ligase New England Biolabs, USA
T5 exonuclease New England Biolabs, USA
GamS Arbor Biosciences, USA
myTXTL-96 Arbor Biosciences, USA
Dyes and purified fluorophores Manufacturer
Enhanced Green Fluorescent Protein BioCat GmbH, Heildeberg
dTomato BioCat GmbH, Heildeberg
DFHBI-1T Lucerna Technologies, USA
Malachite Green solution Sigma Aldrich, USA
TO3-biotin University of Strasbourg
TMR-DN University of Heildeberg
Restriction endunucleases Manufacturer
NheI-HF [20 U/µl] New England Biolabs, USA
EcoRI-HF [20 U/µl] New England Biolabs, USA
SpeI-HF [20 U/µl] New England Biolabs, USA
XbaI-HF [20 U/µl] New England Biolabs, USA
Ladders Manufacturer
Low-range GeneRuler ThermoFisher Scientific, USA
1kb GeneRuler Thermofisher Scientific, USA
RiboRuler Low Range (RNA) ThermoFisher Scientific, USA
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Table 6.14 Buffer composition for diverse routine protocols.
Buffer Composition Final concentration
2x YT + P
2x YT 31 g/L
Potassium phosphate dibasic 7 g/L




Yeast extract 0.5% (w/v)
NaCl 1% (w/v)


























Table 6.16 List of utilised consumables.
Consumable Manufacturer
Dispenser tips Starlab, Hamburg
Nitrile gloves Starlab, Hamburg
Petri dishes Starlab, Hamburg
Pipette tips Starlab, Hamburg
Reaction tubes (1, 1.5, 2 ml) Greiner, Nürtingen
384 well plates, low volume, black Greiner, Nürtingen
384 well plates, white, clear bottom Greiner, Nürtingen
1536 well plates, clear bottom Greiner, Nürtingen
Cellstar© cell culture plates, 12-well/ 24-well Greiner Bio-One, Austria
Breathseal, gas permeable, sterile Greiner Bio-One, Austria
Multiwell plate sealers Greiner Bio-One, Austria
PCR tubes Greiner, Nürtingen
Table 6.15 List of utilised E. coli strains with their corresponding genotype.
Bacterial Strains Genotype
E. coli Top10 F- mcrA ∆( mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74
recA1 araD139 ∆(araleu)7697 galU galK rpsL (StrR)
endA1 nupG
E. coli Dh5α F- ompT gal dcm lon hsdSB(rB- mB-) ∆(DE3 [lacI lacUV5-
T7p07 ind1 sam7 nin5]) [malB+]K-12(∆S)
E. coli BL21 DE3 F- endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG
purB20 γ80dlacZ∆M15 ∆(lacZYA-argF)U169, hsdR17(rK-
mK+), δ -
E. coli BL21 Rosetta 2 F- ompT hsdSB(rB- mB-) gal dcm (DE3) pRARE2 (CamR)
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6.3 Plasmid Constructs
Table 6.17 Plasmids used for expression of synthetic circuits.
Plasmid Name Plasmid architecture Source
pFXL01 J23119 – RBS – sfGFP – T500 – amp – ColE1 origin this thesis
pNoireaux01 P70a – UTR1– RBS – deGFP – T500 – amp – ColE1 origin Noireaux
pNoireaux02 P70a – UTR1– RBS – S28 – T500 – amp – ColE1 origin Noireaux
pFXL02 J23119 – RBS – sfGFP-MGA4x – T500 – amp – ColE1 origin this thesis
pFXL03 J23119 – RBS – sfGFP-Mango – T500 – amp – ColE1 origin this thesis
pNoireaux03 P70a – UTR1– RBS – dTomato – T500 – amp – ColE1 origin Noireaux
pFXL04 P70a – UTR1– RBS – dTomato-iSpinach – T500 – amp – ColE1 origin This thesis
pFXL05 P70a – UTR1– RBS – TPP-OFF-deGFP – T500 – amp – ColE1 origin This thesis
pFXL06 P70a – UTR1– RBS – Theo-ON-deGFP – T500 – amp – ColE1 origin This thesis
pFXL07 P70a – UTR1– RBS – Theo-ON-deGFP – T500 – amp – ColE1 origin This thesis
pJBL2801 J23119 – Target AD1.S5 – RBS – sfGFP – TrrnB – CmR – p15A origin Chappell et al. [13]
pJBL4970 J23119 – Target5 – RBS – sfGFP – TrrnB – CmR – p15A origin Chappell et al. [16]
pJBL5816 J23119 – Target6 – RBS – sfGFP – TrrnB – CmR – p15A origin Chappell et al. [16]
pJBL5808 J23119 – Target8 – RBS – sfGFP – TrrnB – CmR – p15A origin Chappell et al. [16]
pJBL2807 J23119 – STAR AD1.A5 – T500 – AmpR – ColE1 origin Chappell et al. [13]
pJBL4971 J23119 – STAR5 – T500 – AmpR – ColE1 origin Chappell et al. [16]
pJBL5817 J23119 – STAR6 – T500 – AmpR – ColE1 origin Chappell et al. [16]
pJBL5809 J23119 – STAR8 – T500 – AmpR – ColE1 origin Chappell et al. [16]
pJBL-wt J23119 — RBS – sfGFP – TrrnB – CmR – p15A origin this thesis
pJBL-Toehold1 J23119 – Toehold1 – RBS – sfGFP – TrrnB – CmR – p15A origin this thesis
pJBL-Toehold2 J23119 – Toehold2 – RBS – sfGFP – TrrnB – CmR – p15A origin this thesis
pJBL-Toehold3 J23119 – Toehold3 – RBS – sfGFP – TrrnB – CmR – p15A origin this thesis
pJBL-trigger1 J23119 – trigger1 – T500 – AmpR – ColE1 origin this thesis
pJBL-trigger2 J23119 – trigger2 – T500 – AmpR – ColE1 origin this thesis
pJBL-trigger3 J23119 – trigger3 – T500 – AmpR – ColE1 origin this thesis
pJBL-Target AD1.S5-Toehold2
J23119 – Target AD1.S5 – Toehold2 – sfGFP – TrrnB – CmR – p15A
origin
this thesis
pJBL-Target5-Toehold1 J23119 – Target5 – Toehold1 – sfGFP – TrrnB – CmR – p15A origin this thesis
pJBL-Target5-Toehold2 J23119 – Target5 – Toehold2 – sfGFP – TrrnB – CmR – p15A origin this thesis
pJBL-Target5-Toehold3 J23119 – Target5 – Toehold3 – sfGFP – TrrnB – CmR – p15A origin this thesis
pJBL-Target6-Toehold1 J23119 – Target6 – Toehold1 – sfGFP – TrrnB – CmR – p15A origin this thesis
pJBL-Target6-Toehold2 J23119 – Target6 – Toehold2 – sfGFP – TrrnB – CmR – p15A origin this thesis
pJBL-Target6-Toehold3 J23119 – Target6 – Toehold3 – sfGFP – TrrnB – CmR – p15A origin this thesis
pJBL-Target8-Toehold1 J23119 – Target8 – Toehold1 – sfGFP – TrrnB – CmR – p15A origin this thesis
pJBL-Target8-Toehold2 J23119 – Target8 – Toehold2 – sfGFP – TrrnB – CmR – p15A origin this thesis
pJBL-Target8-Toehold3 J23119 – Target8 – Toehold3 – sfGFP – TrrnB – CmR – p15A origin this thesis
pJBL-STAR AD1.A5-trigger2
t500 – trigger2 – J23119 – spacer – J23119 – STAR AD1.A5 – T500 –
AmpR – ColE1 origin
this thesis
pJBL-STAR5-trigger1












t500 – trigger1 – J23119 – spacer – J23119 – STAR6 – T500 – AmpR
– ColE1 origin
this thesis
Continued on next page
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Plasmid Name Plasmid architecture Source
pJBL-STAR6-trigger2
















t500 – trigger3 – J23119 – spacer – J23119 – STAR8 – T500 – AmpR
– ColE1 origin
this thesis
pJBL-wt(red) J23119 — RBS – dTomato – TrrnB – CmR – p15A origin this thesis
pJBL-Target6-Toehold3 J23119 – Target6 – Toehold3 – dTomato – TrrnB – CmR – p15A origin this thesis
pFXL-S6T3MGA








J23119 – Target6 – Toehold3 – sfGFP-MGA4x – TrrnB – CmR –
p15A origin
this thesis
pFXL-P5-deCas9 J23108 – RBS – deCas9 – T500 – AmpR – ColE1 origin this thesis
pFXL-P5-Csy4 J23108 – RBS – Csy4 – T500 – AmpR – ColE1 origin this thesis
pFXL-deCas9-Csy4
J23108 – RBS – Csy4 – T500 – J23108 – RBS – deCas9 – T500 –
AmpR – ColE1 origin
this thesis
pJBL-sgRNA1 J23119 – sgRNA1 – T500 – AmpR – ColE1 origin this thesis
pJBL-sgRNA2 J23119 – sgRNA2 – T500 – AmpR – ColE1 origin this thesis
pJBL-sgRNA3 J23119 – sgRNA3 – T500 – AmpR – ColE1 origin this thesis
pJBL-sgRNA4 J23119 – sgRNA4 – T500 – AmpR – ColE1 origin this thesis
pJBL-sg-trig-star
J23119 – STAR6 – Cys4 - Trigger3 – Cys4 – sgRNA1 – T500 – AmpR
– ColE1 origin
this thesis
pFXL-ion J23119 – ion– RBS – sfGFP-MGA4x – T500 – amp – ColE1 origin this thesis
pFXL-ionC-
J23119 – ion– Csy4 – RBS – sfGFP-MGA4x – T500 – amp – ColE1
origin
this thesis
pFXL-rpiv J23119 – rpiv– RBS – sfGFP-MGA4x – T500 – amp – ColE1 origin this thesis
pFXL-rpivC-
J23119 – rpiv– Csy4 – RBS – sfGFP-MGA4x – T500 – amp – ColE1
origin
this thesis
pFXL-t7 J23119 – t7– RBS – sfGFP-MGA4x – T500 – amp – ColE1 origin this thesis
pFXL-t7C-
J23119 – t7– Csy4 – RBS – sfGFP-MGA4x – T500 – amp – ColE1
origin
this thesis
pFXL-Ag J23119 – Ag– RBS – sfGFP-MGA4x – T500 – amp – ColE1 origin this thesis
pFXL-AgC-
J23119 – Ag– Csy4 – RBS – sfGFP-MGA4x – T500 – amp – ColE1
origin
this thesis
pFXL-Irp J23119 – Irp– RBS – sfGFP-MGA4x – T500 – amp – ColE1 origin this thesis
pFXL-IrpC-
J23119 – Irp– Csy4 – RBS – sfGFP-MGA4x – T500 – amp – ColE1
origin
this thesis
pFXL02-Sd J23119 – Sd– RBS – sfGFP-MGA4x – T500 – amp – ColE1 origin this thesis
pFXL-SdC-
J23119 – Sd– Csy4 – RBS – sfGFP-MGA4x – T500 – amp – ColE1
origin
this thesis
Table 6.18 Plasmids used for protein production.
Plasmid Name Plasmid architecture Source
Continued on next page
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Plasmid Name Plasmid architecture Source
pBADmod1 AraC – Pbad – RBS – GamS – T500 – amp – ColE1 origin Addgene #45833
pmal-cs5x-cys4 LacI– ptac – RBS – MBP – Cys5 – rrnB – amp – ColE1 origin this thesis
Construct examples
















































Continued on next page






























































Continued on next page


































































Continued on next page




































112 Material and Methods
6.3.1 Plasmid Maps
Fig. 6.2 Examples of plasmid architectures based on pJBL2807 (A) and on pJBL2801 backbones (B).
13/08/2019 17:21:04
https://benchling.com/fraximov/f/lib_XX8Naeki-marc/seq_IVNKjzln-pr-trigger2gen-pr-ad1anti/edit 1/1
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Fig. 6.3 Example of plasmid architecture based on pBEST.
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Appendix A
Additional Abbreviations













rpm round per minute
RT Room Temperature
OD600 Optical Density at a wavelength of 600 nM
°C degree Celsius
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